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To understand how maternal thymus influence benzo(a)pyrene [B(a)P]
immunomodulatjon of progeny immunity, adult females were thymectomized
(TX), mated and injected with B(a)P at mid pregnancy. The progeny from TX
and NTX females were evaluated for the effect of thymectomy and B(a)P
exposure on biological factors: cell mediated immunity (CMI), humoral
immunity (HI), and expression of T-cells and subsets. Maternal thymectomy
with B(a)P exposure reduced litter size by 40%. Serological sensitivity of
thymus cells with monoclonal antibody (Mab) anti-CD 1 plus complement
occurred at a higher dilution of Mab in progeny from thymectomized mothers
exposed to B(a)P. Progeny from thymectomized mothers exposed to B(a)P
showed enhanced thymic CMI but suppressed splenic CMI and HI. No
significant difference was observed in the percentage of T-cell subsets
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among treatments. Benzo(a)pyrene treatment resulted in inhibition of
lnterleukin-2 but not of interleukin-2 production. These results indicate that
the thymus plays an important role in modulating the effect of B(a)P on
progeny CMI. Whereas, for HI the role is not as distinctive.
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The thymus is a bibbed lymphoid organ which develops from a paired
epithelial anbage in the third and fourth brachial evagination and descends to
the superior mediastinum. During embryonic development, the thymus is the
first lymphoid organ to appear. The murine thymic rudiment becomes
colonized around day eleven of intrauterine development (Gross and Wayne
Flye, 1993) and T-cell precursors continue to migrate into the thymus
throughout the life of a mammal. Stem cells from yolk sac and fetal liver
colonize the thymus until day 10 of gestation and from day 18 on, the
source of thymic immigrants shift to the bone marrow. In the thymus,
maturation and differentiation of thymus cells lead to the production of
immature L3T4~Lyt2~ and mature L3T4~Lyt2 and L3T4tyt2~ thymus cells,
which concurrently migrate out of the thymus into the periphery. Normal
post thymic T-cells are not resident in any one lymphoid organ but form part
of the recirculating lymphocyte pool (Tizard, 1992). Alterations in thymus
influence may result in changes in the peripheral lymphocyte composition.
Approximately 60% of peripheral cells are L3T4~ and Lyt2~, while there are
35% B-cells and the rest are other hematopoietic elements (Gross and
1
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Wayne-FIye, 1993). T-cells that express L3T4~ molecules recognize
antigens presented by Class II MHC molecules. Whereas Lyt2~ cells
recognize antigens in association with Class I MHC molecules. The ratio of
L3T4~ to Lyt2~ cells in the periphery may be used to estimate lymphocyte
function in clinical situations. An elevated L3T4~ cell count may imply an
increase in lymphocyte reactivity as helper cells predominate whereas, a high
Lyt2~ cell level may indicate depressed lymphocyte reactivity as a result of
excessive suppressor activity (Nikolic-Zugic et al.,1993). In the mouse, T
cell markers that have been characterized include: Thyl or e, Lyti, Lyt2,
Lyt3, L3T4, B220, HSA and LEA-i. In human the equivalent marker for Thyl
is CD1, for Lyti is CD5, for Lyt2 is CD8a, for Lyt3 is CD8I’~ and for L3T4 is
CD4, respectively. There are three main types of T-cells which can be
distinguished according to their function(s) and presence of surface proteins.
These are the helper (Th), suppressor (Ts) and cytotoxic (Tc) T-cells. Mouse
Th cells are characterized by a distinct pattern of surface markers, including
Thyl, Lyti and L3T4 antigens. Two types of T-helper cells are Th-i and Th
2. Th-1 cells are optimized to help cell mediated immune (CMI) response and
secrete lL-2, interferon (IFN)-gamma and lymphotoxin. Whereas, Th-2 cells
are optimized to help antibody formation of B-cells and secrete IL-4, lL-5 and
lL-6. The differences between Th-i and Th-2 cytokine synthesis patterns
lead to markedly different functions (Florentino et al., 1989). Cytotoxic T
cells express the surface molecule CD8a and CD8f~ alloantigen (Sharon and
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Elizabeth, 1994). Cytotoxic T-cells are not necessarily terminally
differentiated and they may eventually differentiate into memory cells (Tizard,
1992). T-suppressor cells, among others, function in the prevention of graft
versus host disease and the immunological destruction of fetuses. T
suppressor cells like cytotoxic T-cells express the surface molecules CD8a
and CD8B alloantigen and the recognition of MHC Class I products.
The principal functions of the thymus include: reception of T-celI
precursor; maturation and the selective release of T-cells to constitute the
peripheral lymphocyte repertoire. In addition, The thymus also play a vital
role in the production of cytokines and thymic hormones. Thymocytes
secrete IL-i, lL-2, IL-4, IL-6, IL-7 and lEN-gamma during the different stages
of T-cell ontogeny. The major producer of IL-i is the activated macrophage.
IL-i is an essential initiation molecule that acts on cells that participate in
immunological or inflammatory responses. It acts on T-cells to cause their
activation and promote lymphokine release. lnterleukin-2 is produced by
CD4~ Th-1 cells in response to appropriate presented antigen or to some
mitogens. Interleukin-2 induces proliferation of activated T- and B- cells and
is thus a key component in the immune response. lnterleukin-4 is derived
from activated Th-2 cells. It acts on T-cells, B-cells, macrophages,
endothelial cells and mast cells. lnterleukin-4 enhances the development of
cytotoxic T-cells from resting T-cells. It can make helper T-cells grow in the
absence of lL-2 and stimulate fetal thymocytes, granulocytes and mast-cell
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growth. The development of normal lymph nodes depend on the functions
of thymic hormones. For example, thymosin stimulates the secretion of
luteinizing hormones which cause the release of hormones from the
hypothalamus that induce the differentiation of murine cortical thymocytes,
stimulate lymphocytes mitogen responses and enhance the production of
interferon and macrophage migration inhibitory factor. Thymulin, also called
Facteur thymic serique, induces T-cell markers on bone marrow cells and
CD3~ cells in the mouse (Bach et al., 1971; Dardenne, et al., 1978).
Thymulin also affects mature T~cells, particularly of the CD8~ subset in a
concentration dependent manner. Thymopoietjn induces early T-cell
differentiation and regulates the function of T-cells. Thymic humoral factor
is essential for induction of clonal expansion, differentiation and maturation
of T-cell subsets. It also augments most T-cell functions. The thymus also
plays an important role early in the development of sexual organs. Infants
with little or no thymus at birth may fail to develop normal gonads (Rebar et
al., 1981).
Numerous authors have correlated thymic alteration with suppression
of immune functions in the periphery. Mechanical and thermal trauma of the
thymus induces decrease in CD4~ cells, lL-2 production and autologous
mixed lymphocyte response (Colic and Lilic, 1991). One method of
determining the essential nature of the thymus was to remove it, and then
measure changes in the immune function. Thymectomy has traditionally
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served as a way of obtaining sources of T-depleted lymphoid tissues (Swain
et al., 1 990a). In the early 20th century, a number of researchers observed
that removal of the thymus in early life not only lead to a cachectic condition
but also impaired resistance to disease. Thymectomized rabbits have
decreased resistance to diphtheria toxin (Gross and Wayne-Flye, 1993). As
early as 1909, Soli suggested that the thymus was important for protection
against infection, proper bone development and sexual maturation (Gross and
Wayne-Flye, 1993). In 1961, Fichtelius et al. indicated that thymectomy
drastically reduced the amount of antibody formation. Adult thymectomy
decreases suppressor T-celI activity while increasing helper and cytotoxic T
cell activity (Takei et al., 1978). Adult thymectomy also abrogates the ability
of surviving T-cells to produce IL-2 (Mosmann and Coffman, 1989). In
recent years, thymectomy has been used to study T-cells and T-cell
precursors (Kirkly and Dennert, 1992; Prayeret al., 1992). The extrathymic
pathway of T-cell differentiation may contribute proportionally more cells in
vivo if the thymus is inactivated or absent (Preffer et al., 1989).
Polynuclear aromatic hydrocarbons (PAH)-related carcinogenesis is
among the most important of occupational diseases attributed to
environmental health impact of the national energy base (Guerin et al.,
1976). Benzo(a)pyrene is one of the PAHs ascribed to smoke released from
power generation, refuse burning and coke production. It has been
demonstrated to possess significant immunotoxic and carcinogenic
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properties. Benzo(a)pyrene is a dangerous environmental pollutant and
strongly carcinogenic in experimental animals (Vesselinovitch et al.,
1 975a;b). Benzo(a)pyrene exerts its carcinogenic and mutagenic effects only
after being metabolized to chemically reactive diol-epoxides (Radhakrishnan
et al., 1979). In mammals, B(a)P is metabolized by the NADPH-dependent
mono-oxygenase system localized on the endoplasmic reticulum.
Benzo(a)pyrene is sequentially subjected to oxidation by the cytochrome P
450 oxidase to form an epoxide, hydration catalyzed by epoxide hydratase
to form a diol, and a second stage of oxidation to yield a diol-epoxide before
the transformation into a powerful electrophile and carcinogen
(Radhakrishnan et al., 1979). The diol-epoxide can then form adducts with
cellular molecules such as DNA, RNA and protein and can act as a mutagen
and a carcinogen (Kapitulnik et al., 1978) which may result in transformation
of the cells (Zedeck, 1980). The subsequent detoxication of the epoxide can
be catalyzed by glutathione transferase to form the corresponding thioether
conjugate with glutathione or by epoxide hydratase which would hydrolyze
the epoxide ring (Mason and Holtzman, 1975). Previous studies in our
laboratory indicate that there is an exacerbated depression in the amounts of
thymocytes as a result of B(a)P exposure to mice (Urso and Johnson, 1987).
Splenic T cell proliferation in the presence of inactivated allogeneic spleen
cells were similarly depressed in B(a)P exposed pregnant and nonpregnant
mice (Urso and Gengozian, 1984; Urso and Johnson, 1988).
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An aspect of maternal-fetal immunologic relationship receiving
considerable little attention is maternal influence on the development of
progeny immunocompetence. Numerous authors have correlated thymic
alterations with suppression of immune function in the periphery. The
perinate depends heavily on receipt of maternal immunologic effectors to
prevent serious diseases or even death in utero or neonatally before it can
build its own protective immunological repertoire. There is considerable
evidence of a mutual exchange of various types of cells and factors between
mother and fetus throughout gestation, but principally during the third
trimester and at parturition (Schroder,1975). The development of immune
competence is a process that requires the sequence migration of a variety of
cell types through non-contiguous tissue during an extended period of fetal
and neonatal life (Thomas and Faith, 1985). Developmental failure or
malfunction of an organ may compromise development of a specific
population of immunocompetent cells (Dean et al., 1983). Previous studies
in our laboratory indicated preferential depletion of maternal circulation
lymphocytes after B(a)P exposure (Urso et al., 1988). Thus, alteration in
these cells by depletion or decreased function would most likely make them
either unavailable for fetal passage or secretion of growth factor for
transplacental migration. Considerable numbers of immunocompetent T
lymphocytes are normally passed to suckling neonates through the colostrum
and milk. Thus alteration in maternal lymphocyte circulation by the
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immunomodulatory action of thymectomy and B(a)P exposure may also make
them unavailable for the suckling neonates (Head and Billingham, 1982).
This may contribute to abnormal development of fetal and neonatal immunity
reflected by quantitative and qualitative defects in the progeny’s T-cells and
subset populations (Hale et al., 1976; McCullagh, 1977; Osaba, 1973).
Chemicals such as B(a)P that affect adult immune capabilities and are
capable of crossing the placental barrier may produce similar or more
profound effects in the developing immune system. Exposure of mice to
B(a)P alters the quantitative expression of T-cell and subsets in lymphoid
organs of the mothers and their progeny (Urso and Johnso,1987; Urso et
al.,1988; Holladay and Smith,1994). Mice exposed to B(a)P in utero
manifest a severe and persistent suppression of antibody plaque forming cell
(PFC) response against sheep red blood cells (SRBC) and cell mediated
immune (CMI) response (Urso and Gengozian, 1980, 1982 and 1984).
Benzo(a)pyrene also exerts its immunomodulatory effects by inhibition of IL-i
or lL-2 production in lymphocytes (Lyte et al., 1987; Lu et al., 1986). The
decrease in IL-2 production could be the basis of induced immune
suppression, exerting its effect on many other lL-2 dependent cellular
immune function, such as reduced T-helper cell functions. The action of
B(a)P that may occur through maternal thymus on the progeny was
suggested by the observation that alterations in maternal T-cell subsets
including depressed Lyti cells and exorbitant increases in Lyt2~ cells in the
9
spleen during later pregnancy imaged the increase in Lyt2~ cells in the
progeny fetal liver and spleen and perinatal depression in Thyl + T cell
subsets in progeny thymus (Urso et al., 1986; Urso and Johnson, 1987).
Objective and Specific Aims
Previous studies in our laboratory indicated preferential depletion of
maternal circulating lymphocytes after B(a)P exposure (Urso and Johnson,
1987; 1988). Thus, alterations in these cells by depletion or decreased
functional ability would most likely make them either unavailable for fetal
passage or secretion of growth factors for transplacental migration. This, in
addition to the effects of B(a)P metabolites, may contribute to abnormal
development of fetal immunity reflected by quantitative and qualitative
defects in the progeny’s T-cells and subset population (Hale, et al. 1976;
McCullagh, 1977; Osoba, 1973). However, the influence of the maternal
thymus that may be immunomodulated by the action of B(a)P on the
progeny’s developing immune components including lymphoid and cellular
elements is unknown. This is important with regard to an alteration of
maternal regulatory mechanism(s) that could influence the development of
progeny immune status in utero and post-natally. Thus, immunomodulatory
actions of any carcinogen relative to maternal fetal interactions and
regulatory effects, of the progeny by the maternal thymus and other
lymphoid tissue, needs investigation. Therefore the objectives of the
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research reported here were: (a) To use a mouse model to undertake a more
detailed quantitative and functional analysis of progeny lymphoid tissues
containing cells expressing T-cell differentiation and functional antigens,
including humoral factors; and (b) To further the understanding of how
chemical carcinogens affect ontogenic development of immune components
that may be mediated by the presence or absence of maternal factors as
influenced by exposure to B(a)P. Thus, information from these studies
should allow us to ascertain whether maternal influence under the stimulation
of a chemical carcinogen such as B(a)P may occur through compromising of
immunocompetent T-cell behavior in the progeny in several events including:
modified migrating maternal deficient immune cells; disabled maternal thymus
to produce growth factors important in progeny T-cell differentiation (eg.
interleukin-2, etc.). Thus an efficient and adaptable mouse model that
provides insight on cellular and humoral steps that need to be programmed
during ontogeny would be extremely useful for investigating how the
maternal thymus may be influenced by B(a)P to modify the necessary
maternal-fetal relationship in the development of immune competence in
progeny. From these considerations, the specific aims of this research were:
1. To evaluate the biological and reproductive behavior of mothers and
progeny after maternal thymectomy and B(a)P treatment.
2. To generate a mouse model that would be used to assess early post-
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natal quantitative specific changes in immune cells after maternal
exposure to the chemical carcinogen B(a)P.
3. To assess by serological and functional assay the role of maternal
thymus on the behavior of progeny lymphocytes, including the
immunoassays, the mixed lymphocyte response and antibody plaque
forming cell response after exposure to B(a)P during mid-pregnancy.
4. To evaluate the role of maternal thymus exposed to B(a)P on
production of distinct cytokines such as lL-2 and IL-4 by Th-1 and Th
2 effectors subsets of the progeny, respectively.
CHAPTER II
LITERA TURE REVIEW
Anatomy of the thvmus
The human thymus is a pale lobulated organ located in the thoracic
cavity between the lungs. It is situated in the midline and is located
predominantly in the anterior mediastinum (Gross and Wayne-FIye, 1993;
Tizard, 1992). The organ is a flattened pyramidal shaped structure
composed of two closely opposed right and left lobes which are subdivided
into a number of lobules of loosely packed epithelial cells and are held in
close contact by a fibrous connective tissue sheath that also encloses the
entire organ in a distinct capsule (Cardelli, 1989). The cortex which is the
outer part of each lobule is densely infiltrated with large numbers of rapidly
dividing thymocytes and is very prominent in healthy young animals, but
shrinks to only a thin rim in senescence and in animals subjected to stress or
given corticosteroids. The medulla occupies the central pathway of each
lobe and accounts for about 15% of thymic tissue in young animals (Sprent,
1993). The medulla contains relatively fewer thymocytes and the epithelial
cells are clearly visible. The size of the thymus can vary considerably. It’s
relative size is greatest in the newborn and its absolute size is greatest at
12
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puberty. After puberty atrophy of the thymus occurs and its center is
replaced by fatty tissues. However remnants of the thymus persists into
senescence. The blood supply to the thymus is derived from arteries that
enter through connective tissue septa and run as arterioles along the
corticomedullary junction The capillaries that arise from these arteries enter
the cortex and loop back to the medulla. Thus, the thymic morphologic
arrangement consist of a blood-thymus barrier which regulates the entry of
foreign antigens into the thymic environment (Marshall, and White, 1961).
The thymus is the first of the lymphoid organs to develop (Haynes, 1984;
Papiernik, 1972). The development of normal peripheral lymph nodes depend
on subsequent seeding by small lymphocytes from the thymus.
T-cell ontogeny
The general consensus is that T-cells differentiate in the thymus. T
lymphocyte development within the thymus involves a complex pathway of
thymocyte division and differentiation that is characterized by the acquisition
and loss of specific cell surface antigens. This differentiation process
includes the rearrangements of T-cell receptor (TcR) bearing lymphocytes
(Campana, 1989). According to Haynes (1990), the thymic
microenvironment develops early in human fetal gestation. At 4 weeks of
gestation, the thymic rudiment is formed from ectoderm of the third
pharyngeal cleft and endoderm of the third pharyngeal pouch. At 7 to 8
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weeks of gestation, yolk sac and fetal liver CD4CD8 and surface(s) CD3 T
cell precursors from the fetal liver or yolk sac began to colonize the thymic
epithelial rudiment, followed by rapid expression of other T-lineage surface
molecules. The source of thymic stem cells post-natally changes to the bone
marrow (Lobach and Haynes, 1987; Haynes, 1984). Rabinowich et al.
(1983) indicated that 14-day old mouse fetal liver contains stem cells
capable of giving rise to T as well as B cell functions. Pyke and Bach (1979)
used in vitro migration under agar to study migration of immune fetal liver
cells to thymus rudiments. Owen and Ritter (1969) and Fowlkes and Pardoll
(1989) reported that precursors of T-cells colonize the murine thymus at
about day 11 of fetal life and continue to migrate to this organ throughout
life. Haynes (1990) suggested that T-cells are programmed to committed
lines during fetal ontogeny. Roitt (1994) reported that prothymocytes are
attracted to the thymus by chemotactic factors. Thus, the thymus plays a
crucial role in T-cell development. T-lymphocyte precursors are identified by
the expression of CD1 + molecules. Double negative (CD4CD8)
prothymocytes, upon migration to the thymus, undergo expansion and
differentiation to a double positive (CD4~CD8j prothymocyte population
(Von Boehmer, 1988; Fowlkes et al., 1985). Double negative prothymocyte
subpopulations imply negativity for both CD4 and CD8 markers (Scollay et
al., 1984; Kingston et at., 1985). Based on a flow cytometry assay,
Husmann et at. (1988) reported that through day 15 of fetal development in
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mice, all thymocytes are double negative. Clevers and Owen (1991)
indicated that double positive immature thymocytes comprise approximately
80-85% of the total thymocyte populations and are located primarily in the
cortex. Sprent et al. (1988) suggested that it is at the double positive state
of thymocyte differentiation that negative and positive selection takes place.
Several investigators suggested that negative selection is induced in the
thymus by medullary epithelial cells (Havran and Allison, 1988; Kingston et
al., 1985). Negative selection is a process of deletion or anergy whereby
double positive thymocytes with a potential reactivity for non-sequestered
self antigen are eliminated in the thymus (Sprent et al., 1988; Benoist and
Mathis, 1989). The cortical epithelial cells are the main cell type that
mediate positive selection (Lo and Sprent, 1986; Kisielow et al., 1988;
Benoist and Mathis, 1989). Thymocytes with TcR that fit the MHC-peptide
complex expressed by the cortical epithelium are positively selected and
escape cell death. These surviving thymocytes that will respond well to
foreign antigens are stimulated to proliferate and migrate to the peripheral
lymphoid organs such as spleen and lymph nodes (Gross and Wayne-Flye,
1993). Studies conducted by Reichert et al. (1984) suggested that most
cells leaving the thymus are single positive CD4~CD8 or CD4CD8~ cells.
Thus the thymus contributes to the pool of peripheral T-cells by releasing
migrants with relatively mature phenotype (Stutman, 1978). Approximately
65% of peripheral T-cells are CD4~ and 35% CD8~ (Gross and Wayne-Flye,
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1993; Von Boehmer, 1988). CD4 is a cell-surface glycoprotein that is
expressed on most thymocytes and T-lymphocytes of the helper inducer
phenotype. The CD4 molecule plays an important role as an accessory
molecule in the recognition of Class II MHC protein (Haars et al., 1991).
Whereas, the CD8 molecule plays an important role in the recognition of
Class I MHC protein (Paterson and Williams, 1987). The CD8~ cells develop
into cytolytic T-Lymphocytes after antigenic stimulation (Shortman et al.,
1988).
Differentiation of precursor thymocytes into mature, functional T-cells
is controlled by signals delivered through the TcR (Shores et al., 1994).
Several researchers suggested that the most critical event in thymocyte
maturation is the expression of the TcR heterodimer on the cell surface
(Sprent et aL, 1988; Kisielow et al., 1988; Sha, 1988; Teh et al., 1988).
Havran and Allison (1988) indicated that y/6 TcR~ double negative
thymocytes are present in the thymus from day 13 of fetal life. Whereas a!
B TcR~ DN thymocytes are first detectable at about 14-18 days of fetal life
and accumulate with age. Penit and Vasseur (1988) indicated that the
appearance of TcR in CD4~CD8~ thymocyte populations correlates with the
ability to proliferate. T-cell receptor expression gradually reaches mature
levels after positive selection.
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Thymectomy
The thymus is very sensitive to various stresses and injuries, reacting
typically by acute involution and subsequent regeneration. Acute involution
can be attributed to massive thymocyte apoptosis, predominantly of the
double positive (CD4~ CD8j phenotype. This results in significant decrease
in total number of single positive (CD4~ CD8) thymocytes of the helper!
inducer phenotype in peripheral blood, reduced IL-2 production and
impairment of most lL-2 dependent cell functions. Trauma also causes
significant ultrastructural phenotypic and functional changes such as
thymulin production of the thymic microenvironment (Colic and Lilic, 1991).
Hormones such as glucocorticoid are effective in inducing thymic involution
(Kendall, 1988). Thymic involution has been described to accompany normal
pregnancy and weaning (Ito and Hoshino, 1 962a). Direct thymolytic agents
such as X-irradiation (Coggle, 1981), cytostatic drugs (Castaldi et al., 1972)
and toxic agents (Miller et al., 1984) cause thymic atrophy. Drugs such as
colchicine when used at the proper dosage have been found to lyse
lymphocytes in the thymus and other lymphoid organs. Therefore, a more
reliable method of determining the essential nature of the thymus was to
remove it and then measure changes in the immune function (Gross and
Wayne-Flye, 1993).
The historical perspective that the thymus might be involved in
protecting the individual against disease was reported in the literature of
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Gross and Wayne-Flye (1993). According to that review, in early 1811 and
1812 Rush and Lucuae, reported the involvement of the thymus in protecting
the individual against disease. In 1860 the relationship between the thymus
and secondary lymphoid organs such as spleen and lymph nodes was clearly
described by His. These observations were further confirmed and extended
in 1909 by Soli that the thymus was important for protection against
infection, proper bone development and sexual maturation. Through its
control of T-cells and their immunological mechanisms, the thymus is
considered to inhibit neoplastic growth (Burnett, 1962). This study
suggested that tumor growth can occur after thymectomy. From the
literature of Gross and Wayne-Flyne (1993), in 1 911, Rohedenberg and
others found that thymectomized rats were more receptive to tumor
transplants. Connolly et al. (1 992) indicated that a short course treatment
of B/w mice with anti-CD4 permanently depletes 90% of CD4 T-cells from
thymectomized mice, whereas thymectomy alone causes a reduction in CD4
T-cells to 35% of circulating lymphocytes. Some intestinal intraepithelial
lymphocytes (IEL) are thymus derived and require further thymic influence to
mature in the periphery (Lefrancojs and Olson, 1994). Removal of the
thymus also removed thymic derived fractions or cells that were necessary
to allow lELs to complete their maturation. Bach (1977) indicated that
thymic extracts induce the appearances of CD1 antigen on negative normal
rosette forming cells (RFC) or on spleen RFC from adult thymectomized mice.
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Several group of authors have reported that a thymic fraction induced an
increase in mitogen responsiveness in thymectomized mice (Swain et al.,
1988a,b; Weinberg et al., 1990; Bass et al., 1989).
The 1960’s witnessed a tremendous surge in the study of the
relationship of the thymus to the immune response (Miller, 1961 and 1962).
There are reports indicating that thymectomy may have an inhibitory effect
on the development of certain neoplasia (Gross and Wayne- Flye, 1993).
Allison and Taylor (1967) indicated a protective effect of thymectomy for
mammary tumor and leukemia. In a similar study r~nnductecI by Haran-Ghero
et al. (1992), a protective effect of thymectomy was observed for lymphoma
in AKR mice. Reinish et al. (1977) reported that thymectomy in young adult
life prevent subsequent development of murine sarcoma. In that study 25
of 30 sham thymectomized mice given murine sarcoma virus developed
lymphoma by 10 months of age, but only 4 of 30 mice that had undergone
thymectomy developed tumors. They suggested that thymectomy either
removed suppressor cells with a resulting enhanced cytotoxic T-cell activity
against syngeneic tumor cells, or removed lymphoid organs known to be a
site of viral replication. Other investigators have also confirmed that
thymectomy decreased the incidence and delayed the appearance of
spontaneous virus-induced, chemically-induced and transplantable mammary
tumors (Yunis et al., 1969). Papatestas et al. (1975) and Tsuchiya et al.
(1991) reported that thymectomy arrests the development of symptoms of
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autoimmune diseases such as myasthenia gravis and inhibit the development
of malignant neoplasia.
Thymectomy has traditionally served as a way of obtaining sources of
T-depleted lymphoid tissues (Swain et al., 1990a). In recent years, it has
been used more frequently to study experimental manipulations of T-cells and
T-cell precursors (Kirkly and Dennert, 1992; Prayer et al., 1992). T-cell
mediated immunosurveillance is drawn from experiments utilizing neonatally
thymectomized and athymic mice where an absence or loss of functional T
cells would be predicted to result in an increased incidence of spontaneous
tumor in these mice relative to immunocompetent controls (Daunter and
Mackey, 1981). Neonatal thymectomy results in the loss of nearly all
peripheral T-cells (Miller et al., 1984). Lefrancois and Olson (1994) indicated
that lymph nodes from neonatally thymectomized mice contain 8% CD4 and
2% CD8 cells. Whereas, non-thymectomized control mice lymph nodes
contain 59% CD4 and 16% CD8 cells, respectively. Neonatal thymectomy
result in a profound arrest of intraepithelial lymphocyte development,
resulting in the appearance of immature T-cells in the gut (DeGeus et al.,
1990). In a similar study, Andreu-Sanchez et al. (1991) reported that
neonatal thymectomy results in a diminution of T-cells in the peripheral
lymphoid organs such as spleen and lymph nodes, but is followed by a
marked transient increase in CD1 ~ CD3~ cells in the peritoneal cavity. These
cells exhibit predominantly a double negative (CD4CD8) phenotype.
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Neonatal thymectomy leads to a selective expansion of T-cells bearing the
immature CD3~CD4CD8- phenotype in the peritoneal cavity. Jones et al.
(1990) indicated that neonatal thymectomy aborts deletion of self-reactive
T-cells. In neonatally thymecton,tzed mice, T-cells clones with potential self-
reactive antigenic specificity escape from deletion to the periphery. The
majority of T-cells that escape deletion are in the CD8~ subsets (Hodes et al.,
1989).
Numerous researchers have confirmed that neonatal thymectomy
results in severe depletion of peripheral T-lymphocytes and major defects in
humoral and cellular immune responses (Kappler et al.,1974; Simpson and
Cantor, 1975; Miller, 1964; Andreu-Sanchez et al., 1991). Thymectomy
causes changes in the balance of T-cell subpopulations (Mosmann and
Coffman, 1989; Swain et al., 1 988a,b). Elimination of T-cells subsets could
interfere with hematopoietic regulatory mediators, triggering lymphokine
production that is important for B-cell proliferation (Haran-Ghera et al.,
1992). Borel et al. (1980) suggested that depletion of short lived T-helper
cells diminish generation of suppressor T-cells that affect either T or B-cell
response and abrogate the ability of surviving T-cells to produce lL-2
(Mosmann and Coffmann, 1989). Prolonged absence of the thymus has
been shown to affect T-cells involved in development of cytotoxic T cell
response (Galli and Droge, 1980). One of the most salient manifestations of
neonatal thymectomy is a severe impairment of cell mediated immune
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responses which inhibit the ability of the animals to develop delayed
hypersensitivity and to reject foreign skin grafts (Andersson and Blomgren,
1971; Kappler et al., 1974; Jones et al., 1990). Shimamoto et al. (1980)
suggested that mice thymectomized within 3 days after birth exhibit a
depression in cytotoxicity and antibody production, whereas a delayed
footpad reaction could be elicited in mice thymectomized within 24 hours
after birth. The response to Con A (10 pg/mI) of spleen cells from 6 weeks
old mice thymectomized at 1 day after birth was lower than that in mice
thymectomized at 3 or 7 days after birth. The response to B-cell mitogens
such as lipopolysacchartdes was higher in neonatally thymectomizecj mice
than sham operated mice (Shimamoto et al., 1980). Thus, the response to
T-cell mitogen was impaired in thymectomized mice but the response to B-
cell mitogen was not impaired. Antibody production to sheep erythrocytes
was greatly impaired in neonatally thymectomized mice (Takeya et al.,
1964). Numerous researchers have indicated that mice, rats and hamsters
thymectomized at birth are more susceptible to carcinogenic agents than
normalanimals(Mijleretal 1963; Miller, 1964; Nishizukaetal., 1965). The
capacity to form humoral antibody against sheep red blood cells and
Salmonella typhi was depressed due to lack of thymus derived antigen
reactive cells (Miller, 1962). Neonatal thymectomy in mice decreases the
latent period and increase tumor incidence in malignancies induced by
polyoma virus, SV4O virus and adenovirus (Hotchin, 1 962; Kirschtein et al.,
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1964). Miller (1964) observed that mice thymectomjzed at birth or not later
than 48-72 hr after birth developed a fetal wasting disease characterized by
loss of weight, ruffled fur, hunched posture and diarrhea. In a different
experiment conducted by Humphrey and Parrot (1964), similar syndromes
were observed in hamsters thymectomized at birth. In summary, the
syndromes associated with neonatal thymectomy include lymphocytopenja,
depletion of lymphoid tissues, impaired cellular immunity, impaired antibody
production to T-cell dependent antigens, inability to produce lgE, stunted
growth, susceptibility to infections and early death (Khan, 1978).
Early experiments conducted by Miller (1961) indicated that removal
of the thymus from mice during adult life had little effect on primary humoral
or cellular responses. Later experiments, however, showed that if a long
enough period had elapsed after adult thymectomy, depression in both
humoral and cellular responses could be detected (Miller, 1964 and 1965;
Kappler et al., 1974). Thymectomy in adult has no immediate effect on
immunological capacity presumably because an adequate pool of competent
cells has already been constructed. Only when the pool becomes depleted
do immunological defects with respect to newly encountered antigens
become evident (Miller, 1965). Metcalf (1965) and Stutman et al.(1972)
showed that late after adult thymectomy there is a diminished response to
allograft, an inability to mount a graft versus host reaction and a failure to
make antibodies to proteins and cellular antigens. Adult thymectomy
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decreases suppressor T-cell activity while increasing helper and cytocytic T
cell activity (Takei et al., 1978; Reinisch, 1977). Cantor and Boyse (1977)
reported a 50% decrease of Lyti ~, and Lyt 2,3k cells in the spleen of adult
thymectomized mice. Using a flow cytometry assay, Wiedmeier et al. (1991)
observed no significant difference in the distribution of mature CD4~ or
CD8~ subsets in the spleen of adult thymectomized and Sham
thymectomized animals. Swain et al. (1 990b) suggested that the Th-1
subset has a long lifespan, indicated by persistence up to 40 weeks after
adult thymectomy. Whereas, the Th-2 subset is short lived in that the
majority of cells of this phenotype disappear 5 to 10 weeks after adult
thymectomy. In that study, effector cells able to secrete IL-4 were
generated in cultures of cells from control animals, whereas thymectomized
animals provided poor sources of precursors that could become lL-4 secreting
effectors. These results disagree with those reported by Wiedmeier et al.
(1991) which indicate that peripheral lymphoid organs of thymectomized
animals demonstrate an augmentation in their lL-4 producing capabilities. In
that study, Wiedmejer et al. (1991) indicated that there is a post
thymectomy, time-dependent reduction in the capacity of T-cells from
animals to produce lL-2. At 5 to 6 weeks post-thymectomy, T-cells from
thymectomized animals produce 50% less lL-2 and 100% more lL-4 as
compared to non-thymectomized control animals. Kappler et al. (1974)
suggested that direct 1gM plaque forming cell (PFC) response was not
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depressed in adult thymectomized mice until more than 18 weeks after adult
thymectomy; whereas, indirect lgG PFC response started to fall at about 18
weeks after thymectomy. Kerbel and Eidinger (1972) suggested that
suppressive effects relatively early after adult thymectomy can be attained
provided a marked thymus dependent antigen such as goose red blood cells
(GRBC) is used as a test antigen. Miller (1965) found no differences in the
number of spleen cells secreting antibody against SRBC between mice
immunized one month after adult thymectomy or sham thymectomy. Normal
cells produced 17.95± 1.29 PFC per 106 cells and spleen cells from adult
thymectomized mice produce 20.77 ±2.25 PFC. However, in that study, it
was observed that thymectomized mice challenged 9 or more months after
operation produced less antibody plaque forming cells. Cantor and Boyse
(1975) indicated that within one month after adult thymectomy the
proportion of Thy 1 cells in spleen is decreased by 30-50% which parallel a
marked decrease in a subclass of Thy 1 + spleen cells that form rosettes with
sheep erythrocytes. A combination of adult thymectomy and anti
lymphocyte serum treatment in mice severely suppressed the immune
response to a variety of thymus dependent antigens such as SRBC but
resulted in augmented antibody response of 4-8 fold of thymus independent
polyvinyl pyrrolidone antigen. Simpson and Cantor (1975) demonstrated that
shortly after adult thymectomy, animals develop enhanced primary responses
to alloantigens as well as diminished helper memory responses. The initial
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increase in MLR following adult thymectomy suggest that adult thymectomy
may delete irrelevant lymphoid cells in periphery (Kerbel and Eidinger, 1972).
Spleen and lymph node cells obtained 2 weeks after adult thymectomy were
enriched for MLR activity. The enrichment was no longer manifest 6 weeks
after thymectomy (Mosier and Cantor, 1971; Bierke, 1990). In that study,
anti-BSA helper memory was reduced approximately 5 fold in adult
thymectomized mouse spleen compared with sham control spleen. Mosier
and Cantor (1971) indicated that normal thymus cells respond very poorly in
MLR whereas, in hydrocortisone treated mice, the reactivity of the surviving
cells was greatly increased. This was attributed to the fact that reactivity of
mature cells within the thymus is masked by the large number of immature
cells. Thymectomy and anti-CD4 treatment has been shown to decrease the
T-cell response of mouse spleen cells to a Con A concentration of 1 .25 pg/mI
(Orme et al., 1992). These experiments suggest that secondary responses
that require priming are affected by adult thymectomy whereas primary
responses are relatively unaffected. In general, adult thymectomy enhanced
and prolonged IgE production in rats; impaired suppressor function;
diminished MLR at 7-9 weeks and depleted Thyl + cells from spleen (Khan,
1978). These studies suggest that in the adult, the thymus is still required
for maintaining an efficient immune apparatus.
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Maternal-fetal relationshiD
Numerous researchers have been involved in the study of the maternal-
fetal immunological relationship with the hopes that discovery of the principle
that underlies the fetus resistance to rejection as an allograft may lead to a
therapeutically applicable means of sustaining clinical replacement allografts
and may also aid in terminating or preventing pregnancy by immunological
means. Secondly, light may be shed on the cause of certain cases of chronic
infertility or abortion (Beer and Billingham, 1977; Gill and Repetti, 1979).
The immunological interaction between a mammalian embryo and its mother
is often compared to a successful semi-allograft, a concept mainly derived
from the emphasis attributed to the role that major histocompatibility
complex (MHC) antigen may play in regulating the maternofetal
immunological relations (Beer and Billingham, 1974; Pattillo, 1 981; Gill,
1986). The trophoblastic cells at the interphase between maternal and fetal
tissues provides an efficient buffer zone which would prevent an
immunological attack of the mother against her conceptus (Adinolfi, 1993;
Johnson, 1993). Attention has been focused on the possibility that impaired
immunological reactivity of the mother is responsible for embryo survival.
During gestation, various immune responses, such as graft rejection
(Adnresen and Monroe, 1962), responsiveness to mitogen (Hsu, 1974) and
response to allogeneic lymphocytes (Ceppelini et al., 1971) are decreased.
It has long been held that the mammalian placenta acts as a functional
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barrier in preventing transmission of maternal cells to the fetus or vice versa.
However, given the close relationship between the maternal and fetal blood
streams and the large expanse of tissue in the placenta, there is considerable
evidence for a mutual exchange of various types of cells between pregnant
mouse and fetus throughout gestation, but principally during the third
trimester and at parturition (Schroder, 1975; Smith et al., 1961; Macris et
al., 1958). Cohen et at. (1964) indicated that about 30% of pregnant
women have fetal red cells in their blood during the third trimester and this
rises to 50% when examined post-partum. Schroder (1975) suggested that
Rh immunization is caused by fetal erythrocytes from Rh-positive fetuses
which enter the circulation of Rh-negative mothers. In that study and in a
similar one conducted by Schroder (1974), quinacrine staining of Y
chromosomes was used to demonstrate that 0.01 % to 0.2% of fetal
leucocytes, including lymphocytes, are transmitted from fetus to the mother.
Also using chromosome studies, Walknowska et at. (1969) observed the
presence of cells with a male karyotype in the circulation of mothers carrying
a male fetus. These cells were interpreted as fetal lymphocytes that had
been transplacentally transferred from the fetus to the mother. In that study,
about 75% of mothers who gave birth to a boy had Y-chromosome
containing cells in their blood during pregnancy. Osoba (1973) suggested
that the fetal thymus produces humoral factors that pass through the
placenta into the maternal circulation and influences the maternal
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immunological system. Kramer and Gershwin (1976) indicated that labelled
fetal thymocytes migrated primarily to the maternal liver and spleen (24.3
and 11 .0% respectively). Globerson et al. (1975) reported that embryonic
liver cells can interfere with the proliferative response of adult lymphoid cells
to allogeneic stimulation. In that study, the effect was noted, when the
stimulating cells were either syngeneic or allogeneic with the liver cells,
without any relevance to the developing immune system.
During pregnancy, the maternal thymus undergoes involution
characterized by diminished size and severely decreased number of cortical
thymocytes (Ito and Hoshino, 1962). These thymic changes reflect basic
alterations in maternal lymphocyte subpopulations. It appears that abnormal
development of immune components in progeny is influenced by changes
occurring in the mother (Chaouat and Viosin, 1979; Clark et al., 1986).
Villee and Dethier (1976) observed that, if the thymus is removed in a non-
pregnant adult female mice, the lymph nodes remain small and are
functionally deficient in cellular immunity, a situation that may influence
progeny immune status. A study conducted by McCullagh (1977) showed
that the frequency of wasting disease was 6-fold higher in neonatally
thymectomized offsprings from thymectomized mothers than in neonatally
thymectomized offspring from mothers with intact thymus (86% wasting
versus 4%, respectively). Kramer and Gershwin (1976) indicated that
spleen cells from nude mice born from heterozygous mothers has
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significantly higher levels of Thyl-bearing cells than mice born from
homozygous mothers. Also, heterozygous nude mice readily rejected skin
grafts whereas homozygous nude mice showed no sign of rejection at 100
days. However, these investigators noted that the Thyl -bearing cells in both
experimental groups were minimally stimulated by T-cell mitogens, Con A
and PHA. Homing experiments of 51Cr thymocytes in term-pregnant nude
mice suggested that the enhanced T-cell characteristics of nude mice born
of heterozygous mothers are caused in part by placental transfer of
allogeneic maternal lymphocytes. Fujii and Yamaguchi (1992) demonstrated
that maternal CD4~ T-cells of immunized pregnant mice induced suppressor
T-cells in their offsprings. In that study, when pregnant female mice were
immunized intraperitoneally with 2 x 106 SRBC, the production of anti-SRBC
PFC in offspring was suppressed. Yranzo-Volunte and Rierra (1990)
observed that a state of specific tolerance to rat male accessory glands
(MRAG) was induced in syngeneic female offspring born from mothers
immunized with MRAG.
Numerous investigators have reported that maternal lymphocytes can
be detected in the fetus and newborn either by their ability to transverse
through the placenta (Geha and Reinhera, 1983) or from colostrum (Weiler
et al., 1983). Desai and Creger (1963), using in vitro atabrime fluorescent
labeled leucocytes that were returned to the mother’s bloodstream just
before delivery, demonstrated that more than half the fetuses had labeled
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leucocytes in their circulation, and one third had labeled maternal
lymphocytes. In a similar study in which 51Cr labeled lymphocytes were
administered to female mice late in pregnancy, the offspring contained some
radioactivity, suggesting that radiolabeled cells in the maternal circulation
have crossed the placenta (Kramer and Gershwin, 1976). Tuffrey et al.
(1969), using T6 marker, demonstrated the presence of maternal cells in the
thymus, spleen and bone marrow of the fetus. El-Alfi and Hathout (1969)
showed that cells carrying the XX chromotype were frequently detected in
the peripheral blood of male newborns with hypospadias and bifid scrotum.
Shimamura et al. (1994) reported that maternal melanoma and sarcoma
metastasized to the fetus. In that study and in a previous study conducted
by Shimamura et al. (1992) paternal major histocompatibility complex
negative cells were found in fetuses of F1 mice bred from allogeneic parents.
The transmission of maternal cells to the fetus was confirmed using
fluorescence activated cell sorting. About 0.3% of maternal cells were
identified in the neonatal spleen. Butler (1974) suggested that the fetal
membranes are impermeable to all antibody classes, but the mammary gland
can concentrate large amounts of certain lgG subclasses in the colostrum
and pass these on to the suckling infant. Also, considerable numbers of
viable leucocytes are normally present in the colostrum and milk and are
passed to suckling neonates. In vitro studies on these cells from human milk
revealed that they are capable of performing immunological functions such
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as mixed lymphocyte reactions, proliferative responses to mitogens as well
as to bacterial and viral antigens (Head and Billingham, 1982). Hamilton et
al. (1988) indicated that GVDH disease develops in response to paternally
derived histocompatibility antigens of the fetus when sufficient numbers of
maternal lymphocytes cross the placental barrier into immunologically normal
fetuses. In support of this, Hale et al. (1976) reported that nude mice from
homozygous nude parents which lack a thymus show a decrease in antibody
plaque forming cell response to sheep red blood cells than nude mice from
heterozygous mothers, whose thymuses are intact. The minimal response
of the nude mice is genetically attributed to a deficiency of thymus derived
helper cells which are essential for an optimal PFC response to thymus
dependent antigen such as sheep erythrocytes. In this context, it is known
that immunological capability and the amounts of circulating lymphocytes of
the progeny from thymectomizecj mothers are depressed as compared to
those from non-.thymectomized mothers (Osoba, 1973; McCullagh, 1977).
Smith et al. (1961) and Macris et al. (1958), respectively, demonstrated the
presence of maternal erythrocytes in the fetal blood stream using cells
tagged with a radiolabeled 51Cr or having an easily recognized hereditary
defect.
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Effect of benzo(a)Dyrene and other Dolynuclear
aromatic hydrocarbons oji the immune system
Polynuclear aromatic hydrocarbons(PAH) are noxious substances
ubiquitous in the environment and they exhibit a cancer inducing effect in
various animal species (Grimmer and Misfeld, 1983). PAH occur in
petroleum, coal, coal tar soot and tobacco smoke (Hardin et al., 1992;
Mudzinske, 1993). PAH measured in skin oil obtained from the forehead of
roofing workers average 100 ng/cm3 (Wolff et al., 1982) and from exposed
skin of road paving workers was about 1400 ng/cm3 (Jongeneelen et al.,
1988). VanRooij et al. (1993) reported a daily skin contamination of PAH
averaging 192 ng/cm2 in workers in the aluminum industry. PAH related
carcinogenesis is among the most important of possible occupational
diseases (Guerin et al., 1 976). Benzo(a)pyrene is one of the PAH ascribed
to smoke released from dense industrial, commercial and domestic sources
that are dangerous environmental pollutants (Grimmer and Pott, 1983) and
strongly carcinogenic in experimental animals, particularly in mouse progeny
during fetal life (Bulay and Wattenberg, 1971; Vesselinovitch et al., 1975b;
Nikinova, 1977).
About 1,300 tons of the carcinogenic B(a)P are released into the
environment of the United States each year from sources such as power
generation, refuge burning and coke production (Levin et al., 1978). The
estimated annual emission of B(a)P in the United States from automotive
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exhaust is 22 tons (Begeman and Burgan, 1970; Hangebrauck et al., 1967),
heating, 475 tons (Hamburg,1969), refuge burning, 563 tons (Wadleigh,
1968) and Industrial plants, 200 tons (Smith, 1970). A single commercial
coal liquification plant will produce 7 kg of B(a)P daily (Sawicki et al., 1962).
Grimmer and Pott (1983) indicated that the concentration of B(a)P in steel
mills at top side of coke ovens and wall tarring operations can reach values
of from 300 to 6000 pg/rn3 of air. Van Schooten et al. (1990) reported that
coke oven workers are exposed to 7.8 pg/rn3 of B(a)P. These environmental
saturations lead to exposure of humans to carcinogenic hydrocarbons in air,
water and food. A rough index of human exposure to B(a)P reach about 100
pg/rn3 in heavily polluted air, 23 ng/liter in drinking water and 100 pg/kg in
smoked food (Baum, 1978). International Agency for Research on Cancer
(IARC, 1986) reported that the total amount of carcinogenic compounds
including B(a)P that one inhales in smoking one pack of cigarettes per day is
about 40 pg. In developing countries, a one hundred pound woman, often
carrying an infant and cooking for 5-6 hr per day, in a small living enclosure
under primitive conditions, inhales at each breath up to 19.3 pg of B(a)P per
m3 of air from cooking fuel smoke (Aggarwal et al., 1982; Smith et
aI.,1983). Many carcinogenic PAH in wood or cattle dung and cigarette
smoke have been shown to be immunosuppressive in animals, while their
non-carcinogenic analogs have no immunosuppressive effects (Dean et
aI.,1983). Conney (1982) noted that application of 0.4 pM of B(a)P every
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2 weeks to the skin of mice for 60 weeks resulted in a 90 to 100 percent
tumor incidence. Numerous in vitro methods such as mammalian cell
transformation (Casto et al.,1978), mutagenesis assay in mammalian (Hsie
et al. (1978) and microbial systems (McCann et al.,1975) have been tested
to correlate with in vivo systems for the identification of potential
carcinogenic agents. The most widely accepted in vitro assay is the Syrian
hamster embryo cells transformation by PAH using mass culture and colony
assay technique (Berwald and Sachs, 1965; Kouri and Schechtman,1977).
The carcinogenic PAH such as B(a)P and DMBA induce transformation foci
whereas the non-carcinogenic PAH are ineffective (Casto et al., 1978).
Greife and Warshawsky (1993) suggested that concurrent administration of
ferric oxide and B(a)P result in decreased latency and increased incidence of
lung tumors in hamsters compared to the administration of B(a)P alone.
Lakowicz et al. (1979) examined the smoking habits of asbestos workers and
found that the smokers had a 92-fold increased risk of lung cancer compared
to non- smokers. Similar synergy with cigarette smoking has been observed
among other workers who are exposed to particulate matter such as coke
oven (Lloyd, 1972) and uranium mine workers (Arcker et al., 1973).
Polycyclic aromatic hydrocarbons comprise a large class of
environmental contaminants that exert their cytotoxic, mutagenic and
carcinogenic effects only after metabolic activation to reactive metabolites
(Wood et al. 1 977a,b). Benzo(a)pyrene is an important member of the PAH
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which exert it’s carcinogenic and mutagenic effect only after being
metabolized to chemically reactive diol-epoxides (Radhakrishnan et al.,
1979). In mammals, B(a)P is metabolized by the NADPH-dependent
monooxygenase system located on the endoplasmic reticulum. NADPH
cytochrome P-450 reductase, phospholipid and cytochrome P-450 function
in the liver microsomal monooxygenase system. Benzo(a)pyrene is
sequentially subjected to oxidation by the cytochrome P-450 oxidase to form
an epoxide, hydration catalyzed by epoxide hydratase to form a diol and a
second stage of oxidation to yield a diol-opoxido before the transformation
into a powerful electrophile and carcinogen (Radhakrishnan et al., 1979).
The diol-epoxide can then form adducts with cellular molecules, such as
DNA, RNA and protein and can act as a mutagen which may result in
transformation of the cells (Zedeck, 1980). The subsequent detoxication of
the epoxide can be catalyzed by glutathione transferase to form the
corresponding thioether conjugate with glutathione or epoxide hydratase
which would hydrolyze the epoxide ring (Mason and Holtzman, 1975). The
levels of a particular form of cytochrome P-450 is a critical determinant of
whether a compound is carcinogenic, mutagenic or toxic in that tissue
(Thomas et al., 1979). Pezzuto et al. (1978) indicated that cytochrome P
448 exclusively participates in the epoxidation of trans-7,8-dihydrodjol-7,8.
dihydrobenzo(a)pyrene. Brookes and Lawley (1964) and Buty et al. (1976)
demonstrated a good correlation between the carcinogenic potency of the
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metabolites and the extent of their binding to DNA. Numerous researchers
have indicated that 7,8-diol-9, 10 epoxide (BPDE) is responsible for the bound
adducts (Borgen et al., 1973; Dandel et al., 1975; Sims et al., 1974).
Kootstra et al. (1989) reported that BPDE preferentially binds with guanine
residue at a region containing two consecutive guanine-cytosine box
consensus sequences. Perera et al. (1994) observed a dose-response
relationship between exposure and PAH-DNA adducts among iron foundry
workers. Rojas et a!. (1994) found about 533 adducts per 10 nucleotides
in samples obtained from lung cancer patients exposed to PAH.
In a study using rodent intraembryonal technique, Barbieri et al. (1986)
observed that injection of 0.4 nmole BPDE per embryo at 10 days of
development resulted in 85% of malformed fetuses. These studies and
numerous others (Levin et al., 1978) have led to the conclusion that BP—7,8
diol is a proximate carcinogenic metabolite of B(a)P, and BP-diolepoxide is an
ultimate carcinogenic metabolite of B(a)P.
Several investigators observed depressed thymus dependent antibody
(TDAb) production following/n vivo B(a)P exposure (Stjernsward, 1966; Urso
and Gengozian, 1980; Dean et al., 1983; Lyte and Bick, 1986; Blanton et
al., 1986) and also following in vitro exposure of normal spleen cells to B(a)P
(Lyte and Bick, 1986; Blanton et al., 1986; White and Holsapple, 1984).
Mice injected with B(a)P at a concentration of 40 mg/kg body weight daily
for 14 days were incapable of generating humoral immune responses
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equivalent to those seen in vehicle injected or untreated mice (Blanton et al.,
1986). Dean and Murray (1991) demonstrated that mice exposed to B(a)P
produce a significant reduction in serum antibody titers after immunization
with SRBC. Blanton et al.(1 988) demonstrated that splenocytes from B(a)P
treated mice show more than 95% inhibition in their ability to form anti-SRBC
plaque forming cells when compared to vehicle treated controls. Lyte et al.
(1987) observed about 78% inhibition in IL-2 production when B(a)P was
administered to mice at a concentration of 40 mg/kg body weight compared
to vehicle control animals.
Other carcinogenic types of PAH include: Benz(a)anthracene (Slaga et
al., 1978; Wood et al., 1977a), chrysene (Wood et al., 1977b) and 3
methyicholanthrene (Vigny et al., 1977). 7-1 2-Dimethylben(a)anthracene
(DMBA) is a methyl-substituted PAH and has been shown to cause skin
cancer and tumors in mice (Heidelberger, 1975), mammary cancer and
adrenal necrosis in rats (Diamond, 1971; Wheatley et al., 1966), as well as
cytotoxicity to cytolytic T-Iymphocyte cells grown in culture (Diamond et al.,
1968). Huberman and Sachs (1977) reported that DMBA in the presence of
the microsomal activation system, covalently bind to the guanosine
nucleotide of cellular DNA and subsequently lead to transformation, mutation
and cell death. Bolognesi et al. (1991) observed up to 100% of mammary
tumor incidence when 55-day old sprague-Dawley female rats were exposed
to DMBA. Mice exposed to DMBA manifest a depressed antibody response
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to sheep erythrocytes (Malmgren, 1952) and cell mediated immunity (Ward
et al., 1986). Pallardy et al. (1989) noted an inhibition of IL-2 production
and lL-2 high affinity receptor expression in DMBA treated mouse
splenocytes. Malmgren et al. (1952) demonstrated that exposure of mice to
3-methlycholanthrene (MCA) produces a marked depression in serum
antibody titers following immunization with sheep erythrocytes. In studies
conducted by Wojdani and Alfred (1983 and 1984), MCA was found to
suppress cell-mediated cytotoxicity by 80 percent in T-cells from 3 different
strains of mice and T-coll proliferation following mitogen stimulation.
Maternal fetal transDlacental carcinoqenesis
It has been found that many compounds pass through the placenta
and reach the fetus. This would offer partial protection to the fetus if the
compounds were metabolized even in part, by the placenta and reduce
toxicity to the fetus. However, since some PAH such as B(a)P must be
metabolized before becoming harmful, placental metabolism may actually
enhance toxicity. Welch et al. (1968 and 1969) found that placenta from
smoking mothers metabolized B(a)P whereas placenta from non smokers did
not (Pelkonen et al., 1972). Filler and Law (1981) have demonstrated the
metabolism of B(a)P by mouse embryo. Maternal cigarette smoking induces
placental aryl hydrocarbon hydroxylase (AHH) activity from the last weeks
of the first trimester onwards (Jachau, 1971; Pelkonen et al., 1972),
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attaining its highest level at term. Stjernfeldt et al. (1986) in a case control
childhood cancer study found that the cancer risk was 50% higher for
offsprings from mothers who smoked more than ten cigarettes per day
compared to offsprings from non smokers. There is ample experimental
evidence that exposure of pregnant animals to chemical carcinogens result
in the occurrence of tumors in their progeny (Mohr et al., 1987). Bulay and
Wattenberg (1971) and Urso and Gengozian (1982) reported that exposure
of mice progeny in utero by injection of 4 to 6 mg/gm body weight of B(a)P
into the pregnant mother during the second trimester led to increased
sensitivity to neoplasia of different types in the offspring. Also, Urso and
Gengozian (1982) showed an increase in sensitivity to immunosuppression.
Cell mediated immune responses of the offspring were suppressed at 1-4
weeks and sustained for 18 months (Urso and Gengozian, 1984). Urso et
al. (1988) observed a reduction in Lyti + and Lyt2~ T-lymphocyte subsets in
the thymus of B(a)P treated mothers. In the spleen, Lyti + subsets were
lower than control whereas Lyt2~ subsets were dramatically enhanced. In
that study and also in a previous study conducted by Johnson and Urso
(1986) a 2-to 4-fold reduction in leukocytes of mice exposed in utero to
B(a)P was observed, whereas a reduction in lymphocytes was observed in
the mothers. Ginns et al. (1982) noted a reduction in circulating CD4~ cells
of the helper/inducer phenotype and CD4/CD8 ratio in blood of people
smoking more than one pack of cigarettes a day, suggesting a relative
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increase in the CD8~ cells of the suppressor/cytotoxic phenotype. In that
study, a decrease in MLR was observed during pregnancy and post-partum.
Urso (1995) showed that in utero B(a)P exposure modifies the capacity of
mice fetal liver cells to augment proliferation in MLR. In that study, normal
fetal liver obtained from 17 to 19 days gestation enhanced proliferation in
mixed lymphocyte culture of allogeneic mixed lymphocyte response. Cells
from fetal liver transplacentally exposed to B(a)P showed a decreased
capacity for augmentation.
Previous research conducted in our laboratory and elsewhere have
shown that in utero exposure to B(a)P alters development of components
needed for establishing competent humoral and cell-mediated functions of
the immune apparatus and lead to severe and sustained post natal
suppression of the defense mechanism (Urso et al., 1988; Urso and
Gengozian, 1984; Urso, 1995; Johnson and Urso, 1986; Vesselinovitch et
al., 1975a and 1975b; Halloday and Smith, 1994). Cervello et al. (1992)
reported that B(a)P given at a dose of 5Opg/g/day to pregnant rats from day
7 to day 15 of gestation significantly increased the number of resorptions
and fetal wastage and also decreased the fetal weight. Benzo(a)pyrene has
been shown to severely suppress the ability of 1-4 wk- old offsprings
exposed at midgestation to produce PFC against SRBC and in the ability of
their lymphocytes to undergo a mixed lymphocyte response (Urso and
Gengozian, 1980 and 1984). Also, in vivo graft versus host response was
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diminished as a result of in utero B(a)P exposure of mice progeny.
Subsequently, B(a)P exposed progeny or their spleen cells were relatively
ineffective in resisting in vivo growth of transferred tumor cells (Urso and
Johnson, 1987). Tumor incidence in the B(a)P exposed progeny are 8-to 10-
fold higher than in the untreated control group at 18-24 months of age (Urso
and Gengozian, 1980 and 1984; Urso and Johnson, 1987; Bulay and
Wattenberg, 1971). Lyte et al. (1987) observed a significant suppression in
IL-2 production from mice exposed in vivo to B(a)P. In that study,
splenocytes from mice exposed in vivo to B(a)P showed a marked decrease
in the percentage of cells expressing IL-2 receptor following 3 days of
culture. Holladay and Smith (1994) observed that/n utero exposure to B(a)P
resulted in severe thymic atrophy, decreased cellularity and altered
expression of thymocytes in mice. In that study, using flow cytometry
assay, it was observed that B(a)P treatment resulted in a significant decrease
in the percentage of double positive (CD4~CD8~) fetal thymocytes as well
as significantly increased double negative (CD4CD8) and single positive
(CD4CD8j thymocytes.
Thymectomy has traditionally served as a way of obtaining sources of
T-depleted lymphoid tissues (Swain et al., 1 990a). In recent years, it has
been used more frequently to study experimental manipulation of T-cells and
T- cell precursors (Kirkly and Dennert, 1992; Prayer et al., 1992). Depletion
of maternal lymphocytes after B(a)P exposure has been observed (Urso and
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Johnson, 1988). Depletion would most likely make them unavailable for
transpiacental passage into the fetus, which may contribute to abnormal
development of fetal immunity and impair fetal protection. The quantitative
and functional alteration in cells of the maternal and progeny lymphoid tissue
after in utero exposure to B(a)P may lead to inability of thymocytes in the
progeny to proceed along predesign cellular pathways. This may result to
disruption in expressing cell surface molecules required in cell differentiation
and production of interleukin-2. Since the thymus has been designated as
the site of T cell-differentiation, the maternal thymic involvement may play
a role in all these factors. Studies addressing the role of the maternal
thymus in the immunomodulatory action of B(a)P on the progeny immune
competence have not been done. Most of the studies reported above left
several unanswered questions. This study was intended to answer some of
these questions: (1) The role of maternal thymus on behavior of progeny T
cells and subsets after exposure to B(a)P during mid-pregnancy; (2) The role
of maternal thymus exposed to B(a)P on Th-1 and Th-2 effector subsets of
the progeny. To attempt to address these questions, a mammalian model
was constructed that could be used to undertake a detailed study of the
mechanism of maternal progeny immunologic relationship involved in
establishing immunocompetency in the progeny that may affect the action
of B(a)P. Thus, this model allows us to address the influence of maternal
thymus on the post-natal ontogeny of the immune system by examining the
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modulatory effects of the chemical carcinogen B(a)P on cellular and humoral
components, particularly T-cells and their subsets. This methodology should
provide insight not only on the direct effect of B(a)P but also effects that are
related to maternal mediation of progeny immune status.
CHAPTER III
MA TERIALS AND METHODS
Materials
Mouse strains C3HEB and Balb/CJAXDBA/2JAX)F., were purchased
from Jackson Laboratories, Bar Harbor, ME. They were housed 5 per cage
at the Morehouse School of Medicine animal facility. They were fed Purina
laboratory rodent chow ad Pibitum.
All surgical instruments used for mice thymectomy were purchased
from Roboz Surgical Company, Rockville, MD. Sodium pentobarbital used to
anaesthetize the mice prior to surgical thymectomy was purchased from
Sigma Chemical Company, St. Louis, MO. The chemical carcinogen B(a)P
was purchased from Aldrich Chemical Company, Milwaukee, WI. Plastic and
glass syringes with needles used for the administration of anesthesia and
B(a)P, respectively, were purchased from Becton Dickinson, Rutherford, NJ.
Trypan blue stain used for the determination of cell viability was purchased
from Sigma Chemical Company, St. Louis, MO. Total cell counts were
determined with Turk’s solution containing Gentian Violet purchased from
LabChem Inc., Pittsburg, PA.
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Goat anti-mouse Thy 1 (used for serological sensitivity test of thymic
CD1 + cells) was raised in goat by intramuscular immunization with
(C3H/AncumxC57Blcum)F1 brain cells emulsified in complete freund’s
adjuvant in our laboratory. Eisen’s balanced salt solution media used for CD 1
sensitivity test was reconstituted in our laboratory from Tris, MgSO4, NaCL
and KCL reagents purchased from Fisher Scientific, FairLawn, NJ. Guinea pig
complement used for CD1 sensitivity test was purchased from Organon
Teknika Corp., West Chester, PA.
Peck and Bach media used for MLR was prepared according to the
procedure developed by Peck and Bach (1973) and supplemented with 2-ME,
NaHepes and NaHCO3 (Sigma Chemical Company, St. Louis, MO). All
sterilized cell culture supplies including 96 well culture plates, petri dishes,
centrifuge tubes and pipettes were purchased from Becton Dickenson,
Lincoln Park, NJ and Corning Inc., Corning, NY. The radioactive chemical
[3H1-thymidjne was purchased from Dupont, New England Nuclear. Cell
filtermats were bought from Skatron Inc., Sterling, VA. The scintillation fluid
was purchased from Fisher Scientific, Fair Lawn, NJ. Scintillation vials were
purchased from Wheaton Scientific, Miliville, NJ. Sheep red blood cells used
for immunization and subsequent determination of PFC were purchased from
Organon Teknika Corp., West Chester, PA. Agarose type II (low melting)
used for PFC (Sigma Chemical company, St Louis, MO).
Monoclonal primary antibodies, mouse lgG2b anti-CD 1 and anti-CD4
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were purchased from Pharmingen, San Diego, CA. Mouse IgG2a anti-CD5
and IgG3 anti-CD8 were purchased from Acurate Chemical and Scientific
Corp., Westbury, NY. Goat anti-mouse lgG2a, IgG2b and IgG3 conjugated
to Fluorescejn isothiocynate (FITC) or phycoerythrin (PE), used as secondary
antibodies in flow cytometry experiments, were purchased from Southern
Biotechnology, Birmingham, AL.
Rosewell Park Memorial Institute 1640 media (RPM I 1640) used for
cell cultures in IL-2 and IL-4 determinations were purchased from GIBCO-BRL
Life Technology, Grand Island, NY. The media was supplemented with FCS
purchased from Hyclone, Logan, UT and other reagents such as
penicillin/streptomycin, L-glutamate and sodium pyruvate purchased from
GIBCO-BRL Life Technology, Grand Island, NY. The Con A
used for spleen cell stimulation in IL-2 experiments was purchased from
Miles-Yeda, Elkart, IL. The T-ceII co-stimulator PMA and the Con A
inactivator alpha-methlmanoside were bought from Sigma Chemical
Company, St. Louis, MO. MOnoclonal mouse anti-lL-2, anti-lL-4 and
recombinant mouse IL-2 and IL-4 were purchased from Collaborative
Biomedical, Bedford, MA. Nutridoma supplement was purchased from
Boehringer Mannheim Corp., Indianapolis, IN. Hamster anti-CD3 used for
activation of spleen cells in lL-4 experiments was purchased from
Pharmingen, San Diego, CA.
Methods
flell Lines
CTLL-2 and HT-2 cell lines used in IL-2 and IL-4 assays, respectively,
were purchased from American Type Culture Collection (ATCC; Rockville,
MD). These cells were subcultured into 75 cm2 culture flask and incubated
at 37°C and 5% CO2 in RPMI 1640 media containing 10% FCS, 10,000
units penicillin/streptomycin, 200 mM L-glutamate, 200 mM Na pyruvate, 5
x iO~ M 2-ME and 25% rat IL-2.
Animals and treatments
The mice used in this study were inbred C3HeB and were housed 5 per
cage at the Morehouse School of Medicine Animal Facility. Mice in all
experiments were fed Purina Laboratory Rodent Chow and given chlorinated
tap water ad fib/turn. Animals were housed in air filtered cages under
controlled condition of temperature (72°C), humidity (68 %) and lighting
(12/12 hours light/dark cycle). The animal facility at the Morehouse School





Adult female mice at 5-8 weeks of age were anesthetized by sub
cutaneous injection of 0.06 p1/gm body weight of a solution of sodium
pentobarbital (6 mg/mI). Each animal was placed ventral side up on a
wooden dissecting board with extremities secured by masking tape in such
a way that the head hung over the proximal edge of the board towards the
operator. Front extremities were taped loosely and pushed toward the body.
A small strip was shaved from the bottom of the rib cage to the throat and
the area was cleaned with 70% alcohol. A mouse-tooth forceps was used
to pick up skin at the top of the sternum and an incision was made with
scissors to just above the second rib. Then, holding the head down with the
left thumb and placing the forefinger on the chest, an incision was made
with scissors just to the right of the anterior sternum through the second rib.
The left hand forceps was positioned to spread the incision open and the
right hand forceps was used to remove both lobes of the thymus from the
cavity. The skin incision was immediately closed with 9 mm autoclips. The
animal was then placed under a lamp for warmth to prevent shock.
ExDosure of mice ~ropeny to benzo(a)Dyrene
The wound was allowed to heal and after one week, the clips were
removed and the female thymectomized mice were mated two females per
male. After detection of a vaginal plug (day 0), the females in one group
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were injected i.p. at 11-13 days of pregnancy with B(a)P dissolved in corn
oil in a boiling water bath, and then maintained at 40°C, at a dose of 1 50
pg/gm body weight. To avoid injecting the fetus, a procedure described by
Tomatis and Pami (1971) was used. In this procedure, a 26-gauge needle
with a 1 ml tuberculin syringe was inserted into the midline of the upper
abdomen immediately beneath the peritoneal wall. By this procedure it is
highly unlikely that the fetus would be directly exposed to the carcinogen.
Controls included: non-thymectomized, uninjected pregnant females
(Normal); non-thymectomized pregnant females injected with the vehicle
(NTX/C0); non-thymectomized pregnant females injected with B(a)P
(NTXIBP); thymectomized and uninjected pregnant females (TX) and
thymectomized and vehicle injected pregnant females (TX/C0).
Biological assays
Some reproductive and biological parameters of the mothers and
progeny born of normal and treated mice such as litter size, survival at day
0 and 28, respectively, sex ratio, pup weight at birth and 28 days, thymus
weight and viability of thymus cells were evaluated to determine reproductive
effect on mothers and the biological behavior of their progeny after
thymectomy and B(a)P treatment. The sex ratio was calculated by dividing
the number of males for each treatment group by the number of males and
females for that group. Thus, sex ratio = male/male +female.
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Viability of thymus cells
Viability of thymus cells was evaluated by the trypan blue dye
exclusion test (TBDE). Previous experiments in our laboratory indicated a
viability greater than 90% in thymuses and spleen cells, respectively (Urso
and Johnson, 1988). In this procedure, seven day-old progeny were
weighed before sacrifice. The thymuses were removed and placed in one
times phosphate buffered saline (lx PBS) maintained on ice. Cells from the
thymus were dispersed singly in culture medium by gently teasing and then
passing the mixture through a nylon sleeve. Total nucleated cells in the
mixture were determined by staining with Turk’s solution and counting them
in a hemocytometer. The viability of the cells (which was greater than 90%
in these suspensions) was determined by the TBDE test. Those cells taking
up the dye and staining blue were considered dead, whereas those that
remained gray and not taking up the dye were considered alive. Viability is
expressed as a percentage.
Serological sensitivity test of thymic CD1 cells
The sensitivity of the progeny thymus cells to goat anti-mouse e plus
complement was assessed by cytotoxicity assay for CD1. Thyl cells
characteristic of CD1 cells has been confirmed by others (Haynes, 1990;
Swain et al., 1990) and in our laboratory (Urso and Johnson, 1988). The
anti-O was highly specific for T-lymphocytes after adsorptions with C3H liver
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and red blood cells. For the anti-CD 1 sensitivity assay, the target cells were
prepared in Eisen’s solution (Urso and Johnson, 1988) and adjusted to a
concentration of 10 x 106 cells per ml. One hundred microliters of the cell
suspension was added to 100 p1 anti-serum with an initial dilution factor of
1:6 and serially diluted to 1:96. The respective mixtures were gently shaken
and incubated on ice for 1 hr. Fifty microliters of guinea pig complement
diluted 1:5 in Eisen’s solution were added and the mixture incubated at 37°C
for 1 hr. The CD1 + cells taking up the dye were scored using the TBDE test
and expressed as a percentage.
Thymic and sQlenic mixed lymDhocyte response
The activities of thymic and splenic T-cells (T cell proliferation against
non-self tissue antigen) were evaluated as described by Urso and Johnson
(1988). Thymocyte and splenocyte responder cells from 7-day old progeny
were cultured with mitomycin C inactivated stimulator spleen cells
(Balb/CJAXDBA/2JAX) F., for allogeneic MLR. The cells were mixed in Peck
and Bach medium (Peck and Bach, 1973) at concentrations of 1 x 106, 0.5
x 106 and 0.25 x 106 of both responder and stimulator cells. A total volume
of 200 p1 per well for triplicate cultures in a 96 well microtiter plate were
incubated at 37°C and 5% CO2 in a humidified atmosphere. On the fourth
day of incubation, the cultures were pulsed with 0.5 p1 per well 3H-
thymidine, specific activity 6.7 Ci/mM. The cells were harvested 16-20
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hours later with a Skatron harvester onto glass fiber filters. The filters were
allowed to air dry and were individually placed into scintillation vials. The
vials were placed in an oven at 50°C for at least 18 hours and radioactivity
(measuring T cell proliferation) was determined in a Beckman LS 5801 liquid
scintillation counter and expressed as CPM. V
Antibody ilapue forminQ cell (PFC) response
A modified version of the hemolytic plaque technique (Urso and
Gengozian, 1973) was used to assess the cooperation between T-cells and
sheep red blood cells for B-cell antibody production against this antigen.
Five-day old mice progeny were injected through the preorbital sinus with
0.02 ml of 10% SRBC suspended in saline solution at a concentration of 10
x iO~ cells per ml. Antibody forming cells were determined on the 5th day
after injection. Harvested spleen cells were washed 3 times in Elsen’s
solution. One hundred microliters of the cell suspension, adjusted to 2.5 x
106; 1.25 x 106 and 0.625 x 106 cells/mI, respectively, were mixed with
0.5% agarose and 7% SRBC at 45°C and quickly poured on glass slides.
After the gel hardened, slides were incubated with guinea pig complement
for 2-3 hr. Plaque forming cells were quantitated with the aid of a dissecting
microscope and expressed as PFC/106 cells.
54
Quantitation of CD1 + CD4~, CD5~ and CD8~ thymocyte subsets
using single stain flow cytometry
To assess the population of CD1 ~, CD4~, CD5~ and CD8~ T
lymphocyte subsets in the progeny thymus, the appropriately stained
preparations were analyzed on a FACScan. In this instrument, a suspension
of cells flow through a very fine bore tube so that they pass through in a
single file. A laser beam is directed through the cell stream and the effect
of the cells on the light beam is measured. The scatter of the light beam in
a forward direction gives a measure of the cell’s size. The scatter to the side
by a cell gives a measure of cell surface roughness and internal complexity.
Thus, if a subpopulation within a cell suspension is labeled with a monoclonal
antibody conjugated to a fluorescent dye, this subpopulation can be
automatically characterized and counted (Tizard, 1992). A thymus cell
suspension (100 p1) adjusted to a concentration of 10 x 106 cells/mI was
added to 10 p1 of primary antibody (Mouse lgG2b anti-CD 1, lgG2b anti-CD4,
lgG2a anti-CD5 or lgG3 anti-CD8, respectively). After two washes, lOpl of
secondary antibody (e.g., goat anti-mouse lGg2b for anti-CD 1, for CD4 goat
anti-mouse lgG2b, for CD5 goat anti-mouse lgG2a and for CD8 goat anti-
mouse lgG3) that is conjugated with fluorescein isothiocynate (FITC) or
phycoerythrin (PE) was added. The treated cells were applied to FACScan
for population analysis of CD1 ~, CD4~, CD5~ and CD8~ T-Iymphocyte
subsets, respectively.
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Quantjtatjon of CD4CD8~. CD4~CD8~, CD4CD8 and CD4~CD8
thymocyte subsets using double stain flow cytometry
To assess the characteristics of the thymic T-lymphocyte
subpopulations as defined by CD4 and CD8 cell surface markers, cells were
labeled with two different fluorescent dyes (FITC and PE) and analyzed on
FACScan. In this assay, for example, a thymus cell suspension (100 p1)
adjusted to a concentration of 10 x 106 cells/mI was added to 10 p1 of
mouse lgG2b primary antibody. Ten microliters of a secondary antibody,
goat anti-mouse lgG2b conjugated with FITC was later added. After
thorough washing, mouse lgG3 anti-CD8 was added followed by goat anti-
mouse IgG3 PE. The treated cells were then applied to FACScan for
population analysis of T-cell subsets (McHugh, 1991).
Proliferation of mouse sDlenocytes with Con A
Harvested unfractionated splenocytes from one week old mouse
progeny were suspended in RPMI 1640 media supplemented with 10,000
units penicillin/streptomycin, 200 mM L-glutamine, 100 mM Na-pyruvate and
5 x 1 0~ M 2ME. A total volume of 200 p1 of cell suspension adjusted to 1
x 106 cells per well were added to various concentrations of Con A
and used to polyclonally induce all T-cells in a 96 well microtiter plate
incubated at 37°C and 5% CO2 in a humidified atmosphere. At 2-4 days of
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incubation, the cultures were pulsed with 0.5 p1 per well of [3H]-thymidine
(specific activity 6.7 Ci/mM). Cells were harvested 16-20 hr later and
radioactivity (measuring T-cell proliferation) was determined in a Beckman
liquid scintillation counter and expressed as CPM.
lnterleukin-2 assay
lnterleukjn-2 produced by lymphocytes was measured by the
proliferation of CTLL-2 cell line, an IL-2 dependent clone. Harvested
unfractionated spleen cells from one week old mice progeny were incubated
at a concentration of 5 x 106 cells/mI with 2.5 pg Con A for 48 hr (optimal
conditions). The supernatants were harvested and methylmanoside was
added to inactivate any residual Con A that might influence the results.
CTLL-2 cells at concentration of 5 x 1 03/well were cultured in RPMI 1640
medium with 25% of the supernate for a total volume of 200 p1/well in a 96
well microtiter plate incubated at 37°C and 5% CO2 in a humidified
atmosphere. On the second day, the cultures were pulsed with 0.5 pCi per
well [3H1-thymidine (6.7 mCi/mM). The cells were harvested 24 hr later and
radioactivity measuring T-cell proliferation determined in a Beckman liquid
scintillation counter, was expressed in CPM.
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lnterleukin-4 Assay
Spleen cells were suspended in RPMI 1640 medium supplemented
with 1 % nutridoma, 10,000 units penicillin/streptomycin, 200 mM L
glutamine and 5 x iO~ M 2ME. The cells were cultured with hamster anti-
mouse CD3 monoclonal antibody diluted 1:200 plus 10 ng per ml phorbol
myristate acetate for 24 hr. The supernatants were harvested and assayed
for IL-4 using a modified HT-2 cell line bioassay procedure (Mosmann, 1983;
Wiedmeier et al., 1991). In this assay, IL-4 responsive cell line HT-2 was
used as an indicator cell. Twenty five percent dilutions of IL-4 supernatant
were prepared in a 96 well microtiter plate using RPMI 1640 medium as
diluent for a total volume of 200pl per well. HT-2 cells at a concentration of
5 x 1 0~ per well were cultured in the presence of anti-lL-2 Mab at 37°C and
5% CO2 in a humidified atmosphere for 48 hr. Additional controls included
testing samples on HT-2 cells alone or in the presence of both anti-lL-2 and
anti-IL-4 antibodies. On the second day, the cultures were pulsed with 0.5
pCi per ml [3H]-thymidine. The cells were harvested 18 to 24 hours later and
radioactivity (measuring T-cell proliferation) was determined in a Beckman
liquid scintillation counter and expressed in CPM. The basal proliferation due
to IL-4 activity for each sample was calculated as the difference between the
aliquot containing anti-IL-2 and anti-IL-2 plus anti-lL-4, respectively.
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Presentation of data
In these studies, data were presented as means (average) ± standard
deviation of means (SDM). Statistical significance were determined by two
way analysis of variance (ANOVA) and Scheffe’s multiple comparison test.
One-tailed student’s t-test was used to measure groups against each other.
CHAPTER IV
EXPERIMENTAL RESULTS
PostoDeratjon survival of thymectomized mice
The surgical thymectomy was well tolerated, because there was no
difference in mortality between the non-thymectomjzed (Figure 1) and
thymectomjzed (Figure 2) mothers during the postoperative period. Upon
examination of a group of thymectomized mothers complete ablation of the
thymus lobes was achieved. When the progeny were sacrificed for
immunoassay no thymic remnants were observed in the thymectomized
mothers.
The effect of thymectomy and benzo(a)rjyrene treatment on
reproductive behavior in mice
There was a significant decrease (p < 0.01) in litter size, pup survival
at 28 days and male to female sex ratio in non-thymectomized B(a)P treated
and thymectomized B(a)P treated females relative to non-thymectomized
uninjected controls (Table 1). However, no effect was seen on survival at
birth. The decrease in litter size from progeny of thymectomized mothers
exposed to corn oil is significant at p< 0.01 from progeny of non
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Figure 1. Representative adult non-thymectomized primiparous female
mouse showing the location of intact thymus.
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Figure 2. Representative adult thymectomized primiparous female mouse
showing absence of thymus tissue.

Table 1. The Effect of Thymectomy and B(a)P Treatment
on Reproductive Behavior of Mothers
Percent of Control
Factor NTX/CO NTXIBP TX TX/CO TX/BP
Number of Progeny 98 69 105 78 68
Litter size 99 ± 3 8 69 ± 4C* 104 ± 68 79±2 b 60+3 d
Survival at birth 100 a 97 ± 18 100 a 98 ± 2 97 ± 2
a a b
~ Survival at 28 days 100 88 ± 1 100 95±2 87 ± 2
a b a dSex Ratio Male/Female 88±4 56±3 80+4 36±2 40 + 1
Values are average ± standard deviation. Number of mothers = 9. Superscripts a,b,c,d in the same row
differ at p< 0.05. Superscripts a,b,c.d~ in the same row with asterisk differ at p < O.0l.Student’s t-test
was applied to compare values of control and experimental for each factor. Superscript b differ from
control at p <0.05; c, p <0.005; d, p <0.0005. Superscript b differ from control at p <0.01; c, p
<0.001; d, p <0.0001. Control values for number of progeny was 65; Average litter size was 7.2;
Survival at day 0 and 28, 100% and Sex ratio 0.71.
0)
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thymectomized B(a)P treated and thymectomized B(a)P treated mothers.
Biological behavior of Drogeny born of normal and treated Mice
There was a slight increase in pup weight and a 2-fold increase in
thymus weight at birth from progeny of thymectomized B(a)P exposed
mothers relative to untreated control (Table 2). The increase in thymus
weight in progeny from thymectomized mothers exposed to B(a)P was
significantly different (p< 0.01) compared to untreated control. Progeny
from non-thymectomized mothers exposed to B(a)P showed a decrease in
thymus weight (p < 0.01) relative to untreated control. However, at 7 days
postnatal the average weight of pups from thymectomized B(a)P treated
mothers was slightly lower relative to untreated control. The thymus weight
of progeny from thymectomized mothers exposed to B(a)P was significantly
(p< 0.01) lower compared to untreated control. The total number of
thymocytes was reduced at birth as a result of B(a)P exposure which was
sustained up to 7 days post-natal. Spleen weight and cellularity were also
reduced as a result of thymectorny and thymectomy and B(a)P exposure.
The viability of thymocytes in all the experimental groups were not
significantly different from untreated control.
Table 2. The Effect of Thymectomy and B(a)P Treatment
on the Biological Behavior of Progeny
Percent of Control -______________________
At birth Factor NTXICO NTXIBP TX TX/CO TXIBP
Pupwt 107±4’ 8O±2d 87±1 C 113~2b 120±2”
Thymus weight 100±lb 67±4 c’ 100~1b’ 100~3b° 2OO±3~’
Viability of a a a a a
Thymus cells 101±1 100±2 104±4 101+1 99+2
Thvmus
Cellularity 93±1 b 64±2 C’ 107+28 ~ b 71±2 C’
Spleen weight 100 ± ~ a 67± 1 b’ 100±4 a 100 ±3 a a
Spleen • b
Cellularity 83±3 33±1 116±28 93~3 50±3
1 Week Pup weight 98±2 a 84±2 b 86 ± 2 b 88 ± ~ b 91±2 b
Thymus weight ~ 62±4 ° 79±2 b’ 78±4 b’ 76±2 “
Thymus C a b d
CellularIty 97±3 80±3 94±2 90±1 74±2
a C’ b b CSpleen weight 85±1 68±4 ~~±5 ~ 69±2
Spleen C b d
Cellularity 89±1 74±2 83~3 82±3 67±2
Values are average ± standard deviation. Numbers of mothers = 9. a,b,c,d,e superscripts differ at p
<0.05; a,b,c,d,e’ superscripts with asterisk differ at p <0.01; ‘Student’s t-test was applied to compare
values of control and experimental for each factor. Superscript b differ from control at p <0.05; c, p
<0.005; d, p <0.0005; e, p <0.00005. Superscript b’ differ from control at p <0.01; c’, p <0.001;
d, p <0.0001; e,p <0.00001. Control factors are as follows: At birth; Pup wt. 1.5 gm; Thymus wt.
3.0 mg; Thymus cells viability 92%; Thymus cellularity 7.0 x 106; Spleen wt. 3.0 mg; Spleen cellularity
3.0 x 106. At I wk; Pup wt. 5.7 gm; Thymus wt. 29.5 mg; Thymus cellularity 75.6 x 106; Spleen




Serological sensitivity of thymocytes from progeny born of
thymectornized mothers exposed to benzo(a)pyrene
To assess the sensitivity of thymocytes from progeny born of
thymectomjzed mothers and exposed to B(a)P, cell suspensions containing
1 x 106 cells were incubated with anti-Thy 1 that was serially diluted from
initial concentration of 1:6 to a final dilution of 1:96, with guinea pig
complement added to each dilution. At 1:6 monoclonal anti-Thy 1 dilution,
all the cells in the various treatment groups were Thy 1 + as shown in Table
3. However, at 1:96 dilution, the percent dead cells were 68 ± 8.7 for
thymectomized and B(a)P treated; 46 ± 4.5 for non-thymectomizeci and
B(a)P treated compared to 21 to 28 for the various control groups for a 2 -3
fold higher frequency of cell death. These results show that cytotoxicity with
monoclonal anti-thy 1 plus complement occurred at a higher dilution of Mab
in progeny from thymectomized mothers exposed to B(a)P, suggesting a
greater sensitivity of the B(a)P thymus cells toward destruction by Mab and
complement that appear to be exacerbated by thymectomy.
Effect of thyrnectomy and B(a)P exDosure on thymic
mixed lymi,hocyte resDonse
To evaluate the capability for the MLR by thymus cells of progeny
from thymectornized and B(a)P exposed mothers, responder cells were
cultured with stimulator cells and [3H]-thymidine uptake was determined on
Table 3. Serological Sensitivity Test of Thymic CD1
Cells (7 Day Old Pups)
Goat antl-CD1 Percent Dead Cells
dilution factor Normal NTX!CO NTXIBP TX TX/CO TXIBP
1:6 ioo 100 100 100 100 100
1:12 92 ±l.Ob~ 92 ±l.5b g~ ~10b’ 93 ±i.2~ ~ l.0~ 98 ±0.6’
1:24 81 ± 2.1 b 82 ± 0~6b 90 + 0.6’ ~ ± 2.1 b~ 84 ± 1.7 b 91 ± 3•5’
C c a b b a1:48 55 ± 7.6 57 + 1.0 76 ÷ 1.5 62 ± 1.5 64 ± 0.6 80 ± 5.5
1:96 21 ÷1~5d 2315d 46~45b’ 26±4.6C* 28+4.4c 68+8.7’
Values are average ± standard deviation. Number of mothers = 9. a,b,c,d superscripts differ at p
<0.05; a,b,c,d~ superscripts with asterisk differ at p <0.01. * Student’s t-test was applied to compare
values of control and experimental for each factor. Superscript b differ from control at p <0.05; c, p




the 5th day. An exacerbated enhancement of thymic mixed lymphocyte
response occurred in progeny of thymectomized females exposed to
B(a)P relative to non-thymectomized uninjected control (Figure 3). The CPM
for the non-thymectomized uninjected controls was 8.9 x iO~ ± 0.6 x iO~
compared to 22.2 x iO~ ± 0.7 x iO~ for the progeny of thymectomized
mothers exposed to B(a)P; 17.2 x iO~ ± 0.4 x ‘iO~ for thymectomized and
corn oil treated; and 13.4 x io~ ± 2.5 x iO~ for progeny from
thymectomized uninjected mothers respectively. The cell counts in the
above treatment groups were significantly higher (p< 0.01) than the
untreated control group. These results expressed as percent of untreated
control show that progeny thymus cells from thymectomized mothers
exposed to B(a)P have a 2.5 fold increase in MLR. However, progeny
thymus cells from non-thymectomjzed mothers exposed to B(a)P show
significantly (p < 0.01) reduced proliferation of 3.0 x iO~ ± 0.2 x iO~ for
60% decrease compared to progeny thymus cells from untreated control.
Effect of thymectomy and benzo(a)pyrene exposure on splenic
mixed lymphocyte response
The data in Figure 4 indicate that thymectomy and B(a)P exposure
decreased mice progeny spleen cell proliferation in MLR compared to the
untreated control. Also, thymectomy and corn oil exposure induced a severe
suppression in MLR identical to those from thymectomized and B(a)P treated
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Figure 3. Thymic mixed lymphocyte response of 7-day old progeny born of
normal or thymectomized mothers exposed in utero to benzo(a)pyrene. Each
bar represent the mean CPM of progeny from 8 different litters (one
progeny/litter). Range of CPM for normal control group was 8.3 x 1 o~ to 9.5
















Figure 4. Splenic mixed lymphocyte response of 7-day old progeny born of
normal or treated mothers. Each bar represent progeny from 8 different
litters (4 progeny/litter). Range of CPM for normal control groups was 11 .2
x iO~ to 18.5 x iO~ for 8 experiments. Vertical lines represent standard
deviations from the mean.

















progeny. The mean [3H]-thymidine uptake for progeny of non-thymectomized
uninjected mothers was 16.1 x iO~ CPM compared to 6.8 x iO~ for progeny
of thymectomized mothers exposed to B(a)P; 7.3 x 1 0~ for thymectomized
and corn oil treated and 14.6 x iO~ for progeny from thymectomized
uninjected mothers, respectively. When the response of treated cultures was
expressed as percent of the control, a significant inhibition (p <0.01) was
detected for thymectomized and B(a)P treated (45% of control) and
thymectomized and corn oil treated (48% of control), respectively.
Effect of thymectomy and benzo(a)pyrene exposure on humoral immunity
To determine the effect of maternal thymectomy and B(a)P exposure
on the PFC response of treated and untreated mice progeny, sensitized
spleen cells were cultured in vitro with SRBC by the technique of hemolysis
in gel and the PFC evaluated on microscopic slides. The data in Figure 5
show that mice progeny from thymectomized or non-thymectomized mothers
exposed to B(a)P significantly decrease (p< 0.01) splenic PFC response
compared to progeny from untreated control. Progeny from untreated
control had 668 PFC/1 06 cells. Whereas, progeny from thymectomized and
non-thymecton,jzed mothers exposed to B(a)P had 260 and 261 PFC/106
cells, respectively, for a 64% decrease. However, the PFC of progeny from
thymectomized mothers exposed to corn oil was statistically different at p
< 0.05, compared to the untreated control. The PFC counts, although
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Figure 5. Splenic antibody plaque forming cell response of 7-day old progeny
from normal and treated mothers. Each bar represent the mean PFC/1 06 cells
of progeny from 9 different litters (2 progeny/litter). Range of PFC/1 06 cells
for normal control group was 592 to 696 for 9 experiments. Vertical lines











lower, in progeny from thymectomized mothers were not significantly
different from the untreated control.
Effect of maternal thymectomy and benzo(a)Dyrene exposure on
post-natal CDL CD4, CD5 and CD8 thymocyte DoDulations
To evaluate the effect of maternal thymectomy and in utero exposure
to B(a)P on 7-day old progeny, thymocyte expression of CD1, CD4, CD5,
and CD8 cell surface antigens were analyzed by flow cytometry on FACScan.
The limited number of dead cells present were excluded from analysis with
electronic gates. For each sample, approximately 10,000 cells were
collected and analyzed. Representative histograms with one color stain for
CD1, CD4, CD5 and CD8 from control, treated and untreated mice progeny
thymocytes are shown in Figures 6-9, respectively. The percentage of
thymocytes expressing CD1, CD4, CD5, or CD8 cell surface antigens did not
significantly differ among the various treatment groups as shown in Table 4.
The data reported in these figures show that thymectomy and B(a)P
treatment did not distinctively alter expression of CD1, CD4, CD5 or CD8
surface antigens at 7-day post-natal. However, analysis of fluorescence
intensity for CD1 + and CD8~ cells into high and low intensities (data not
shown) indicated that mice progeny from thymectomized or non
thymectomized mothers exposed to B(a)P have a slight decrease in CD1 +Hi
and increase in CD8÷’~ cells
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Figure 6. Flow cytometric profile of CD1 + cells in the thymus of 7-day old
progeny. The staining reaction for CD1 + cells was mouse lgG2b aCD1 +
goat a mouse lgG2b PE. (A) Negative control (normal rat lgG + goat a
mouse lgG2b PE). (B) Progeny from untreated mothers (C) Progeny from
non-thymectomized mothers exposed to corn oil. (D) Progeny from non
thymectomized mothers exposed to B(a)P. (E) Progeny from thymectomized
mothers. (F) Progeny from thymectomized mothers exposed to corn oil. (G)
















Figure 7. Flow cytometric profile of CD4~ cells in the thymus of 7-day old
progeny. The staining reaction for CD4~ cells was mouse lgG2b a CD4 +
goat a mouse lgG2b FITC. (A) Negative control (normal rat lgG + goat a
mouse lgG2b FITC). (B) Progeny from untreated mothers (C) Progeny from
non-thymectomized mothers exposed to corn oil. (D) Progeny from non
thymectomized mothers exposed to B(a)P. (E) Progeny from thymectomized
mothers. (F) Progeny from thymectomized mothers exposed to corn oil. (G)



















Figure 8. Flow cytometric profile of CD5~ cells in the thymus of 7~day old
progeny. The staining reaction for CD5~ cells was Mouse lgG2a a CD5 +
goat a mouse lgG2a PE. (A) Negative control (normal rat lgG + goat a
mouse lgG2a PE). (B) Progeny from untreated mothers (C) Progeny from
non-thymectornized mothers exposed to corn oil. (D) Progeny from non
thymectomized mothers exposed to B(a)P. (E) Progeny from thymectomized
mothers. (F) Progeny from thymectomized mothers exposed to corn oil. (G)


















Figure 9. Flow cytometric profile of CD8~ cells in the thymus of 7-day old
progeny. The staining reaction for CD8~ cells was Mouse lgG3 a CD8 +
goat a mouse lgG3 PE. (A) Negative control (normal rat lgG + goat a mouse
lgG3 PE). (B) Progeny from untreated mothers. (C) Progeny from non-
thymectomized mothers exposed to corn oil. (D) Progeny from non
thymectomized mothers exposed to B(a)P. (E) Progeny from thymectomized
mothers. (F) progeny from thymectomized mothers exposed to corn oil. (G)















Table 4. Effect of Thymectomy and B(a)P Exposure on
Progeny Thymocyte Subsets
Percent Thymocyte Subsets
Subsets Normal NTXICO NTXIBP TX TX/CO TX/BP
CD1 + 98.1 ± 0.2 97.5 ~ 0.6 96.5 ± 0.9 97.4 ± 0.8 96.6 ÷ 0.2 95.7 ± 0.2
CD4~ 92.1 ± 0.2 92.0 ± 0.3 92.3 ± 0.4 90.7± 0.9 92.1 ± 0.5 92.0 ± 0.5
0)
CD5’ 96.5 ± 0.2 96.6 ± 0.3 96.0 tO.6 96.7 ± 0.2 97.0 tO.5 96.6 tO.3
CD8~ 73.2 ±2.8 78.9 ~2.O 74.2 ± 1.5 74.9 ± 1.9 78.6 ±2.6 78.3 ±3.0
Values are average ± standard deviation. Number of mothers = 6.
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compared to progeny from untreated control.
Effect of maternal thymectomy and benzo(a)pyrene exposure on
expression of CD4 and CD8 cell surface antigens
To evaluate the effect of maternal thymectomy and B(a)P treatment
on postnatal thymocyte populations as defined by CD4 and CD8 cell surface
antigens, cells were conjugated with antibodies against CD4 and CD8,
labeled with two different fluorescent dyes (FITC and PE) and assayed by
flow cytometry on FACScan by two color immunofluorescence.
Representative thymocyte profiles in dot plots for CD4 and CD8 T
lymphocytes subsets from control, treated and untreated mice progeny are
shown in Figure 10. Each quadrant represents the percent of cells contained
in that quadrant. The results, summarized in Table 5, show that maternal
thymectomy and B(a)P exposure decrease the percentage of thymocytes
expressing double negative (CD4CD8) and single positive (CD4~CD8) and
(CD4CD8~) cell surface molecules. However, the percentage of cells
expressing double positive (CD4~CD8j cell surface antigen was enhanced
as a result of thymectomy and B(a)P exposure compared to the untreated
control.
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Figure 10. Flow cytometric dot plots of CD4 and CD8 cells in the thymus
of 7-day old progeny. Two color staining reaction for CD4 and CD8 cell
surface antigens was as follows: Mouse lgG2b a CD4 and lgG3 a CD8 +
Goat a mouse lgG2b FITC and IgG3 PE. (A) Negative control ( normal rat
lgG + goat a mouse lgG2b FITC and lgG3 PE) (B) Progeny from untreated
mothers (C) Progeny from non-thymectomized mothers exposed to corn oil.
(D) Progeny from non-thymectomized mothers exposed to B(a)P. (E) Progeny
from thymectomized mothers. (F) Progeny from thymectomized mothers
exposed to corn oil. (G) Progeny from thymectomized mothers exposed to
B(a)P. The percent of cells in each quadrant is represented by the dots
detected in the quadrant. Quadrant ‘I, depicts CD4CD8~. Quadrant 2
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Table 5. Effect of Thymectomy and B(a)P Exposure on Postnatal
Thymocyte Population Defined by CD4 and CD8 Cell Surface Antigen
Percent Thymocyte Subsets
Subsets Normal NTX/CO NTXIBP TX TX/CO TX!BP
CD4CD8 3.4±0.2’ 2.0+0.3’ 1.4±0.3b 34+03a 1.8+o.1~ 1.9+0.4’
CD4~ CD8~ 85 ±. 1.9 a 88 ±. 1.2 a 92±0.3’ 89± 1.1 a 90 ±0.5 a 91 ± 0.7 a
(0
0a a b b a
CD4~CD8 7.7+ 0.1 7.1 ± 0.5 4.8 ± 0.3 4.4 ± 0.3 6.9 ±0.6 5.2 ±0.1
CD4CD8~ 4.0±0.7’ 3.1 ±0.4a 1.8±0.3’ 2.9±0.5’ 1.8±0.1’ 2.0±0.2’
a,b superscripts differ at p <0.05. - Student’s t-test was applied to compare values of control and
experimental for each subset. Superscript b differ from control at p <0.05.
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Effect of maternal thymectomy and benzo(a)~yrene exDosure on
IL-2 Droduction of mice Drogeny sileen cells
To determine the effect of maternal thymectomy and B(a)P exposure
on the Th-1 subset of splenic T-lymphocyte subpopulations, CTLL-2 cells
were cultured with lL-2 produced by the progeny spleen cells and
blastogenic activity was assayed 48 hr later. A preliminary dose test of
CTLL-2 cell response to lL-2 from rat showed optimal response at a dose of
5 x 103/well. The uptake of [3H]-thymidine in CPM is shown in Figure 11 for
3 different doses of CTLL-2 cells. In order to determine optimal Con A
concentration required for spleen cells activation, we carried out first a
preliminary test with various Con A concentrations. Optimal spleen cells
proliferation was obtained at a Con A concentration of 2.5pg/ml RPMI 1640
(Figure 12). Also, optimal lL-2 production assayed by the proliferation of
CTLL-2 cells was obtained at a Con A concentration of 2.5 pg/mI RPMI
1640 when incubated with one week old normal spleen cell (Figure 13).
Subsequently, the activity of lL-2 produced by normal and treated mouse
progeny spleen cells was determined by the ability to support proliferation of
5 x iO~ cells. The results in Figure 14 show that alteration of the maternal
immune repertoire either by thymectomy or B(a)P exposure suppresses the
ability of progeny to produce IL-2. Proliferation of CTLL-2 cells in the
presence of lL-2 from progeny of thymectomized mothers exposed to B(a)P
was 15.6 x iO~ ± 1.4 x iO~ and 13.9 x iO~ ± 1.1 x iO~ for progeny of
92
Figure 11. Proliferation of different concentrations of CTLL-2 cells in the
presence of normal rat lL-2. Each bar represent the mean CPM of 4 different












Figure 12. The Con A concentration required for optimal proliferation of
normal 7-day old progeny spleen cells. Each bar represent the mean CPM of

















Figure 13. Dose response of CTLL-2 cells to lL-2 produced from 7-day old
progeny spleen cells with different Con A concentrations. Each bar
represent the mean CPM of 4 different experiment. Vertical lines represent










Figure 14. Proliferation of CTLL-2 in the presence of IL-2 produced from 7-
day old progeny spleen cells born of normal or thymectomized mothers
exposed to benzo(a)pyrene in utero. Each bar represent the mean CPM of
progeny from 6 different litters (4 progeny/litter). Range of CPM for normal
control group was 23.2 x 1 O~ to 25.1 x 1 O~ for 6 experiments. Vertical lines
represent standard deviations from the mean.
















normal mothers exposed to B(a)P compared to 23.9 x 1O~ ± 1.0 x iO~ for
progeny of untreated mothers. The observed difference in CPM of progeny
from thymectomized mothers exposed to B(a)P and non-thymectomized
mothers exposed to B(a)P was statistically different at p< 0.01 compared
to the untreated control. Thus, IL-2 production was inhibited by the
exposure of mice progeny to B(a)P compared to the untreated control.
Effect of maternal thymectomy and benzo(a)Dyrene exposure
on IL-4 Production of mice proQeny soleen cells
To determine the effect of maternal thymectomy and B(a)P exposure
on the Th-2 subset of splenic T-lymphocyte subpopulations, preliminary
studies were conducted to determine if unprimed fresh spleen cells from
C3HeB mice produce lL-4. HT-2 cells were cultured with lL-4 produced by
mice of different age groups and blastogenic activity was assayed 48 hr
later. In order to determine the optimal lL-4 produced by 6 weeks old mice
using different stimulants, we carried out preliminary tests as shown in Table
6. Optimal lL-4 production assayed by responsiveness to HT-2 cells was
obtained by stimulation of spleen cells with anti-CD3 and PMA. In addition,
• we observed that the optimal concentration of murine recombinant lL-4
required for HT-2 cell proliferation was 250 units/well (Figure 15). Also,
dose response test of HT-2 cells to IL-4 showed, optimal response of 5 x 1 O~
cells/well (Figure 16). Subsequently, the activity of lL-4 produced by























Figure 15. Dose response curve of HT-2 cells to different concentrations of
normal mouse recombinant IL-4. Each point represent the mean CPM of 4









.06 .25 .98 3.9 15.6 62.5 250.00 500.00
Units of IL-4IWeII
104
Figure 16. Proliferation of different concentrations of HT-2 cells in the
presence of normal mouse recombinant IL-4. Each bar represent the mean














Figure 17. Production of IL-4 by normal C3HeB spleen cells cultured with
anti-CD3 and PMA. CPM represents proliferation of HT-2 cells in the
presence of supernatants from different age mice. Each bar represent the
mean CPM of 6 different experiments. Vertical lines represent standard
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Figure 18. Proliferation of HT-2 in the presence of IL-4 produced from 6-
week old progeny spleen cells born of normal or thymectomized mothers
exposed to benzo(a)pyrene in utero. Each bar represent the mean CPM from
2 different litters (one progeny/litter). Vertical lines represent standard
deviations from the mean.















unprimed normal spleen cells from different age groups was assayed by the
ability to support HT-2 cell proliferation. The results in Figure 17 show that
the optimal age of C3HeB mice for IL-4 production is 6 weeks after birth.
The CPM represent proliferation of HT-2 cells in the presence of supernatants
from different age groups. The [3H]-thymidine uptake for 1 week old mice
was 0.07 x 1O~; 1.0 x iO~ for 3 weeks old mice; 7.7 x 1O~ for 6 weeks old
mice and 0.3 x 1 O~ CPM for 6 months old mice, respectively. Based on the
preliminary studies, the activity of IL-4 produced by normal and treated
mouse progeny spleen cells was assayed in 6 weeks old mouse. The results
in Figure 18 showed that maternal thymectomy and B(a)P exposure did not
alter splenic IL-4 production. Proliferation of HT-2 cells in the presence of IL
4 from progeny of normal mothers was 7.5 x iO~ and 7.5 x iO~ from
progeny of thymectomized mothers exposed to B(a)P.
DISCUSSION
We have utilized a mouse model to study how chemical carcinogens
such as B(a)P affect progeny immune status that may be mediated by the
presence or absence of maternal thymus. It is reasonable to assume that the
status of the progeny immune system would be influenced by factors such
as migrating lymphocyte and humoral substances (Head and Billingham,
1982). In this context, it is known that immunological capability and the
amounts of circulating lymphocytes of the progeny from thymectomized
mothers are depressed (Osoba, 1973; McCullagh, 1977). Although other
explanations for the B(a)P induced changes in progeny immune status
following in utero exposure may be plausible, the experimental system
utilized in this study appeared to present a novel approach to elucidating the
relationship between maternal immune status and progeny
immunocompetence.
One important aspect of this study was to evaluate the reproductive
capability of .thymectomized mothers exposed to B(a)P. Our model
established experimentally that maternal thymectomy and/or B(a)P exposure
led to a decrease in litter size, pup survival rate at 28 days and male to
female sex ratio. The decrease in litter size might be induced by the trauma
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effect of i.p. mode of B(a)P exposure rather than a direct cytotoxic effect of
B(a)P on the fetus since pregnant mothers injected with the corn oil vehicle
only also exhibited a decrease in litter size relative to the untreated control.
However,the decrease in pup survival at day 28 strongly suggest the
cytotoxic effect of B(a)P on the neonates since progeny from non
thymectomized B(a)P exposed mothers had a similar decrease in pup survival
as compared to progeny from thymectomized B(a)P exposed mothers. The
results reported here show that maternal thymectomy failed to interfere with
progeny survival at 28 days. There are reports that the sex ratio of infants
born of toxemic mothers are shifted towards a predominance of males
(Toivanen and Hirvonen, 1970). The data presented here show that the
male/female sex ratio for the progeny of non-thymectomized and B(a)P
exposed mothers and progeny from thymectomized and B(a)P exposed
mothers are significantly lower (P < 0.01) than progeny for untreated control
mothers. These findings demonstrated that maternal toxemia did not appear
to occur as a result of exposure of the mothers to B(a)P. It further supports
the notion that maternal thymectomy did not influence reproductive hormonal
balance. Maternal thymectomy and/or (Ba)P exposure did not produce
clinical evidence of toxicity as determined by progeny body weight at birth.
However,we observed an increase in thymus weight at birth in progeny from
the thymectomized mothers exposed to B(a)P compared to the untreated
controls. This may be due to compensatory immunological response of
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thymocytes of progeny from thymectomized mothers to the chemical
carcinogen B(a)P. More studies are needed to clarify this hypothesis.
However, the data presented here show that exposure of progeny from non
thymectomized mothers to B(a)P result in severe thymic atrophy as assessed
by organ weight. This trend is comparable to those reported by our
laboratory (Urso and Johnson, 1987 and 1988) and others (Holladay and
Smith, 1994). The viability of thymus cells assayed by the TBDE test was
not significantly different from controls after maternal thymectomy and in
utero exposure to B(a)P. The viability of the cells in all the treatment groups
was invariably greater than 90% of the control group. This parallels previous
reports by our laboratory (Urso and Johnson 1 988) which also reported
viability greater than 90% of cell suspension from thymuses and spleens.
The total number of thymocytes was reduced as a result of B(a)P exposure,
which was sustained up to 7 days postnatal. Therefore, a reason for the
observed increase in thymus weight at birth may be attributed to increased
epithelial as well as connective tissue matrix in the thymus. Spleen weight
and cellularity were also reduced as a result of thymectomy and B(a)P
exposure. These findings demonstrate that maternal thymectomy and B(a)P
exposure did not appear to alter the viability of progeny thymocytes, but
increased thymus weight.
As a first step to study T-cell profile in the thymus of progeny born of
normal and treated mothers, we evaluated the percentage of Thyl ~ cells
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after treatment with anti-thy 1 and complement. The results reported here
show that cytotoxicity with anti-thyl monoclonal antibody (Mab) plus
complement occur at a higher dilution of Mab in progeny from
thymectomized mothers exposed to B(a)P. The explanation for these effects
may be that maternal thymectomy and B(a)P exposure lead to increase
sensitivity of developing thymocytes to anti-thyl plus complement. In
support of this explanation, Wojdani and Alfred (1983) demonstrated that
cell membrane alterations by PAH resulted in a suppression of the binding
and lytic steps required in cell mediated cytotoxicfty. This may result to the
increased sensitivity of thymocytes from progeny of thymectomized mothers
exposed to B(a)P to anti-CD 1 plus complement.
In order to assess the immune competence of progeny of
thymectomized mothers exposed to B(a)P, we evaluated the thymic MLR of
progeny from treated and untreated mothers. The results obtained in this
study show that thymus cells from progeny of thymectomized mothers
exposed to B(a)P were the most proliferative. Those from thymectomized
mothers but not exposed to B(a)P were intermediate in reactivity. Whereas,
those from non-thymectomized mothers exposed to B(a)P showed a decrease
in MLR as compared to untreated control. These results suggest that
maternal thymectomy increase the ability of thymocytes to recognize
antigens and proliferate in response to non-self tissue antigen.
The above results are in agreement with other published studies
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including Mosier and Cantor (1971) who observed a higher index of
stimulation in hydrocortisone treated thymus cells compared to normal
thymus cells and Urso et al. (1992) who reported a depressed thymic MLR
in 7-day old progeny exposed to B(a)P. Mosier and Cantor (1971)
suggested in their study that although thymus cells were not reactive in one
way MLR, the hydrocortisone resistant fraction contained substantial
reactivity similar to that found in the periphery. This suggest that
anticorticosteroid resistant mature thymocytes consist of cells capable of
responding to foreign alloantigens. The most likely interpretation of this
present study is that thymocytes from progeny of thymectomized mothers
are enriched for MLR activity. The explanation for these effects may be that,
there are mature reactive cells within the thymus whose activity is masked
by the large number of irrelevant immature cells. Adult thymectomy may
delete irrelevant lymphoid cells in the periphery in analogous fashion to the
corticosteroid effect on the thymus and thereby make them unavailable for
transplacental passage to the progeny. Among the deleted population may
be immature cells, normally presented as a recent emigrant from the thymus
which have little or no immediate MLR activity.
Previous studies reported by our laboratory (Urso and Johnson, 1 987)
indicate that in the thymus Lytl ~ cells clearly out number Lyt2~ cells, but in
the spleen Lyt2~ cells are increased 2-8 fold over Lytl cells. The
explanation proposed in that study was that a change in the direction of T
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cell differentiation pathway occurs. There is, therefore, a need to address
extrathymic T-cell differentiation in B(a)P exposed progeny from
thymectomized mothers in greater detail, since the normal patterns of T-cell
distribution in clearly disrupted. It is possible that some of these cells die of
the toxic effect of B(a)P before reaching the peripheral organs. To clarify
these hypothesis, we decided to undertake a detailed study of T-cell profiles
in the spleen. In this study, we evaluated the capability of the splenocyte to
mount an allogeneic mixed lymphocyte response. We found that splenocytes
from progeny of mothers exposed to B(a)P were defective in mounting
allogeneic MLR. Exposure of progeny from non-thymectomized mothers to
B(a)P led to a 37% decrease in allogeneic MLR compared to untreated
controls. Whereas, exposure of progeny from thymectomized mothers to
B(a)P resulted in an exacerbated suppression of MLR. The percentage
decrease in MLR in this case was 55% compared to the untreated control.
These findings agree with those of Urso et al. (1986) who reported a 19%
depression of splenic MLR in B(a)P exposed 7-day old mice progeny
compared to corn oil control. These results also confirm previous results
from Mosier and Cantor (1971) which suggest that thymus cells may require
a period in the periphery to acquire full immunological reactivity.
Surprisingly, a suppression in MLR was also observed in progeny from
thymectomized mothers exposed to corn oil relative to untreated control.
This may be attributed to the presence of small amount of PAH in corn oil
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which may damage the fragile immune repertoire of progeny from
thymectomized mothers, thus leading to suppression in MLR. In support of
this hypothesis, Grimmer and Pott (1983) reported that crude vegetable oils
such as sunflower oil contain about 15.3 pg PAH/kg of oil.
The contrasting results obtained with thymic and splenic MLR led us
to question whether maternal thymectomy will modulate the cooperation
between syngeneic T-and B-cells for antibody production against SRBC. Hale
and Hanna (1976) reported that congenitally athymic mice are severely
deficient in PFC response to SRBC compared to normal mice. The PFC
response of homologous nude mice was 15 times less than those of
heterozygous nude mice. The minimal response of nude mice to SRBC in
that study was attributed to a deficiency of thymus derived helper cells
which are essential for full PFC response to thymus dependent antigen such
SRBC. To further clarify these observations, we reconstituted the direct 1 9S
antibody responses of spleen cells from progeny of normal and treated
mothers against SRBC. Our results show that spleen cells from progeny of
normal or thymectomized mothers exposed to B(a)P are deficient in their
ability to produce antibody response against SRBC as compared to untreated
control. The PFC response of progeny from non-thymectomized and
thymectomized mothers exposed to B(a)P were 61 % less than those of
untreated controls. These results are in agreement with previous findings by
our laboratory (Urso and Gengozian, 1984) regarding the PFC response of
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progeny of normal mothers exposed to B(a)P. In that study, they reported
that progeny exposed to B(a)P in utero showed 50-75% suppression in their
anti-SRBC response at 1 wk of age. An analogous observation as regard to
the effect of adult thymectomy on PFC response has been made by Simpson
and Cantor (1975). In that study, they did not find any significant difference
between normal spleen cells and spleen cells from thymectomized mice in
their ability to produce PFC against SRBC. Normal spleen cells produced
17.95 PFC/106 cells. Whereas, spleen cells from thymectomized mice
produced 20.77 PFC/106 cells. The explanation of this finding is that
progeny from thymectomized mothers have a sufficient number of antigen
reactive cells in their lymphoid organs at birth, but exposure of these organs
to B(a)P alters development of components needed for establishing
competent humoral functions of the immune apparatus and leads to severe
post-natal suppression of the defense mechanism. However, it is not known
whether the effect of B(a)P on the progeny immune competence is primarily
on T or B cells, but previous studies by Urso and Gengozian (1973) on
humoral antibody formation after parenteral injection of antigen suggest T
cell deficiency on the basis of their failure to form 7S antibody.
The abnormalities in the T-cell mediated responses led us to examine
the quantitative profile of T-cells and subsets present in the progeny thymus
post-natally, using a flow cytometry assay. The results in this study show
that maternal thymectomy and B(a)P exposure did not significantly alter the
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expression of CD1, CD4, CD5 and CD8 cell surface molecules at 7 days
post-natal. However, analysis of CD1 + and CD8~ cells based on high and
low fluorescence intensities indicate that expoèure of mice progeny to B(a)P
led to a slight decrease in CD1 +Hi and enhancement in CD8÷’~ thymocytes
compared to untreated control. Our finding are comparable with those of
Urso and Johnson (1987), who observed that mice progeny exposed to B(a)P
have a significant reduction of CD1 + cells at 1 5 days of gestation but at
other time intervals the frequency was mostly similar to that of controls. In
that study, the frequency of CD5~ cells was depressed during gestation and
on the first post-natal day while that of CD8~ cells was in general similar to
the controls. Further, dose response studies conducted by Dean et al.
(1983) in adult mice revealed that the most pronounced immunologic defects
occurred at the highest dose (200-400 pg/g body weight). From our data,
the changes in T-cell subsets were not obvious at 7 days post-natal.
However, we cannot rule out the possibility that precursors of T-cells die
from the toxic effect of B(a)P before reaching the thymus.
Although the peripheral T-ceIl pool contains only single positive CD4
or CD8 cells, a large subset of thymocytes are positive for both molecules.
Recent evidence suggests that double positive cells may be precursors of
mature single positive lymphocytes (DeLibero and Lanzavecchia, 1989).
Holladay and Smith (1994) reported that exposure of pregnant mice to B(a)P
resulted in a significant decrease in the percentage of double positive
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(CD4~CD8j fetal thymocytes and a significant increase in double negative
(CD4CD8) and single positive (CD4CD8~) thymocytes. In the present
study, double stain flow cytometric analysis was employed to specifically
examine the T-cell profile in the thymus of 7-day old progeny of
thymectomized mothers exposed to B(a)P. These cells show a stable double
positive phenotype but give rise in vivo to quantitatively lower single positive
variants compared to the untreated control. We did not observe any
significant difference in the double negative phenotype among the various
treatment groups, except those from non-thymectomized mothers exposed
to B(a)P. These results suggest that if a toxic effect did occur in thymus it
does not become apparent for up to 1 wk post-natally after in utero exposure
to B(a)P.
Reports describing the effect of B(a)P on immunocompetent cell
function have often relied on observations of immunological assay systems
such as mixed lymphocyte response and plaque forming cell response. Little
has been accomplished toward directly defining the sensitive target cells. In
light of studies demonstrating that B(a)P suppressed lL-2 responsiveness and
reduced lL-2 production by T-cells (Lyte et al., 1987), the present study was
undertaken to gain further insight on how B(a)P may affect TH-1 cell function
in progeny from thymectomized mothers. Splenocytes from treated and
untreated mice were stimulated with Con A to induce IL-2 production. IL-2
activity in 48 hr supernatants was assessed by ability to support growth of
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the IL-2 dependent CTLL-2 cell line as measured by [3H]-thymidine
incorporation into proliferating cells. The data are presented as IL-2 activity
rather than as a complete titration curve to allow better comparison of lL-2
production between treatment groups. The results showed that suppressed
production of IL-2 was most dramatic in mice progeny exposed to B(a)P
compared to that obtained in the untreated control group. It appears that
maternal thymus does not mediate B(a)P elicited alteration in progeny
splenocyte production of IL-2, since the levels of IL-2 produced in both
thymectomized and non-thymectomized mothers exposed to B(a)P are
similar. Our data are more in line with those studies which find that lL-2
production is decreased following in vivo B(a)P exposure (Blanton et. al.,
1988; Lyte et al., 1987). The results reported in our study support the
conclusion made by Swain et al. (1990) and Weidmeier et al. (1991) that
there is a post-thymectomy time-dependent reduction in the capacity of T
cells from animals to produce IL-2. In these studies, the amount of lL-2
produced by activated splenic T cells obtained from thymectomized animals
at 2-4 weeks post- thymectomy was not significantly different from the
amount of lL-2 produced by a similar population of cells taken from sham
thymectomized animals. However, when the period of the time post
thymectomy exceeded 6 weeks, the amount of lL-2 produced by T-cells from
the thymectomized animal progressively declined.
There is evidence of Th-1 to Th-2 shift with disease progression
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(Clerici and Shearer, 1993). Several investigators have reported that cells
capable of IL-4 production in lymphoid population freshly isolated from mice
are rare in comparison with those producing IL-2 when the cells were
stimulated with antigens or mitogens (Powers et al., 1988; Weinberg et al.,
1988). Here, we characterized Th-2 subsets of CD4~ cells by examining
normal spleen cell populations instead of T-cell lines. We found that fresh
spleen cells stimulated with anti-CD3 plus PMA produce little or no lL-4 at
1 to 3 weeks of age and at 6 months of age. Powers et al. (1988) reported
a similar low pattern of lL-4 secretion in unprimed spleen cells. In this study,
the optimal age for lL-4 production in C3HeB mice was found to be about 6
weeks. However, maternal thymectomy and B(a)P exposure did not alter the
secretion of IL-4 by mice progeny spleen cells. The above results are in
agreement with other published studies including Li and Miller (1993) who
observed age-associated decline in IL-4 production by murine T-lymphocytes
in extended culture and Wiedmeier et al. (1991) who did not find any
significant difference in the lL-4 producing capabilities of lymphocytes from
thymectomized and sham thymectomized mice. These results suggest that
cells from naive animals capable of producing lL-4 were very rare in
comparison with those cells producing lL-2. It further indicate an age
dependence in the capability of unprimed spleen cells to secrete lL-4. The
contrasting results obtained in the modulatory effect of B(a)P on lL-2 and IL-4
production by mouse spleen cells suggest that Th-1 and Th-2 cell functions
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This study was conducted to examine how chemical carcinogens
affect progeny immune components that may be mediated by the presence
or absence of maternal thymus. It is known that B(a)P given to non
thymectomized (NTX), females quantitatively and qualitatively alters the
expression of T-cell subsets and suppresses cell mediated immunity (CMI)
and humoral immunity (HI) in progeny and mothers. Parallel enhancement
also occurs in CD8~ cells. In this study,thymectomy had little influence on
the mother,s reproductive capability but maternal thymectomy with B(a)P
exposure reduced litter size of the progeny by 40%. Alteration of biological
parameters included, decreased survival at 4 weeks in progeny from
thymectomized and B(a)P injected mothers. Thymus cell death in the
presence of the monoclonal antibody anti-Thyl plus complement occurred at
a higher dilution of Mab in progeny from thymectomized mothers exposed to
B(a)P. Maternal thymectomy and B(a)P treatment enhanced MLR by 60% in
the thymus but inhibited splenic MLR by 58% and splenic PFC by 62%.
Maternal thymectomy and B(a)P treatment did not appear to have a
quantitative effect on the percentage of CD1 ~, CD4~, CD5~ and CD8~
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progeny thymus cells. No significant differences were observed in the
percentage of double positive (CD4~CD8~) and double negative (CD4CD8)
thymocytes among the various treatment groups. Benzo(a)pyrene treatment
resulted in 42% inhibition in IL-2 production but maternal thymectomy did
not influence the suppressive effect of B(a)P on progeny splenic lL-2
production. This suggested a non-maternal thymic effect on progeny Th-1
cells. Maternal thymectomy and exposure to B(a)P failed to alter production
of IL-4 by Th-2 subset of splenic T-lymphocytes. This study also indicated
that Th-2 cells capable of producing IL-4 are very rare in naive animals
compared to Th-1 cells producing lL-2.
In conclusion, the results of this investigation show that the maternal
thymus plays an important role in modulating the effect of B(a)P on progeny
CMI but a role not as distinctive for HI status. Although B(a)P treatment
inhibits the progeny lL-2 production, it appears that maternal thymectomy did
not enhance the modulating effect of B(a)P on Th-1 cell functions. The most
likely interpretation of these results is that spleen and lymph nodes cells were
enriched with mature T-cells for transplacental passage to the fetus after
adult thymectomy. Since exposure of mice progeny to B(a)P did not alter IL
4 production, it is most likely that lL-2 and IL-4 production are regulated
through different pathways.
In view of maternal-fetal relationship we examined postnatally, the
quantitative and functional profiles of progeny T-cell populations that may be
125
126
mediated by the presence or absence of the maternal thymus as influenced
from exposure to B(a)P. This study is the first known to have used a
mammalian model to study the immunomodulatory actions of any carcinogen
relative to maternal-fetal interactions and regulatory effect on the progeny by
maternal lymphoid tissue. There is, therefore, a need to address extrathymic
T-cell differentiation during fetogenesis and early postnatal in greater detail
using this model. Since a thymic role is suggested in this study, in
modulating the effect of B(a)P on progeny CMI, implantation of a normal
syngeneic thymus under the maternal kidney capsule of previously
thymectomized mice before B(a)P injection should be investigated to
ascertain if B(a)P exposure would provoke changes in progeny resembling
those seen in progeny from non-thymectomized mothers.
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